<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998112</article-id><article-id pub-id-type="pmc">PMC11861417</article-id>
<article-id pub-id-type="doi">10.3390/toxins17020095</article-id><article-id pub-id-type="publisher-id">toxins-17-00095</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Insights into the Role of Proteolytic and Adhesive Domains of Snake Venom Metalloproteinases from <italic toggle="yes">Bothrops</italic> spp. in the Control of <italic toggle="yes">Toxoplasma&#x000a0;gondii</italic> Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Samuel C.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref><xref rid="fn1-toxins-17-00095" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>Thales A. M.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-toxins-17-00095" ref-type="aff">2</xref><xref rid="fn1-toxins-17-00095" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>de Souza</surname><given-names>Guilherme</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Luz</surname><given-names>Luana C.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Paschoalino</surname><given-names>Marina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Junior</surname><given-names>Joed P. de L.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Rosini</surname><given-names>Alessandra M.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>Aryani F. F.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>de Freitas</surname><given-names>Vitor</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af3-toxins-17-00095" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2462-4163</contrib-id><name><surname>Lopes</surname><given-names>Daiana S.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><xref rid="af4-toxins-17-00095" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Clissa</surname><given-names>Patr&#x000ed;cia B.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af5-toxins-17-00095" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>de Souza</surname><given-names>Vin&#x000ed;cius C.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af2-toxins-17-00095" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2410-0562</contrib-id><name><surname>Nishiyama-Jr.</surname><given-names>Milton Y.</given-names></name><xref rid="af2-toxins-17-00095" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Barbosa</surname><given-names>Bellisa F.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7447-2583</contrib-id><name><surname>Ferro</surname><given-names>Eloisa A. V.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-toxins-17-00095" ref-type="aff">1</xref><xref rid="c1-toxins-17-00095" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>&#x000c1;vila</surname><given-names>Veridiana de M. R.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af3-toxins-17-00095" ref-type="aff">3</xref><xref rid="c1-toxins-17-00095" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-17-00095"><label>1</label>Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberl&#x000e2;ndia, Uberl&#x000e2;ndia 38405-318, MG, Brazil; <email>samuel.teixeira@ufu.br</email> (S.C.T.); <email>guisbio@hotmail.com</email> (G.d.S.); <email>luanacarvalholuz.28@gmail.com</email> (L.C.L.); <email>marinapaschoalino@gmail.com</email> (M.P.); <email>joedjunior07@gmail.com</email> (J.P.d.L.J.); <email>monteirorosini_alessandra@hotmail.com</email> (A.M.R.); <email>felixafajardo08@gmail.com</email> (A.F.F.M.); <email>bellisafb@ufu.br</email> (B.F.B.)</aff><aff id="af2-toxins-17-00095"><label>2</label>Laboratory of Applied Toxinology, Butantan Institute, S&#x000e3;o Paulo 05503-900, SP, Brazil; <email>t.fernandes.proppg@proppg.butantan.gov.br</email> (T.A.M.F.); <email>vinicius.souza.esib@esib.butantan.gov.br</email> (V.C.d.S.); <email>milton.nishiyama@butantan.gov.br</email> (M.Y.N.-J.)</aff><aff id="af3-toxins-17-00095"><label>3</label>Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Universidade Federal de Uberl&#x000e2;ndia, Uberl&#x000e2;ndia 38405-318, MG, Brazil; <email>vitor_freitas_@live.com</email></aff><aff id="af4-toxins-17-00095"><label>4</label>Institute Multidisciplinary in Health, Universidade Federal da Bahia (UFBA), Vit&#x000f3;ria da Conquista 45029-094, BA, Brazil; <email>lsdaiana@ufba.br</email></aff><aff id="af5-toxins-17-00095"><label>5</label>Laboratory of Immunopathology, Butantan Institute, S&#x000e3;o Paulo 05503-900, SP, Brazil; <email>patricia.clissa@butantan.gov.br</email></aff><author-notes><corresp id="c1-toxins-17-00095"><label>*</label>Correspondence: <email>eloisa.ferro@ufu.br</email> (E.A.V.F.); <email>veridiana@ufu.br</email> (V.d.M.R.&#x000c1;.); Tel.: +55-34-3225-8569 (E.A.V.F.)</corresp><fn id="fn1-toxins-17-00095"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>95</elocation-id><history><date date-type="received"><day>14</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>17</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Toxoplasmosis is an alarming public health problem that affects more than one-third of the world&#x02019;s population. In our work, we investigated the antiparasitic effects of catalytically active [BpMP-I and Jararhagin (Jar)] and catalytically inactive [Jararhagin-C (Jar-C)] snake venom metalloproteinases (SVMPs) in human HeLa cells. These toxins impaired the parasite invasion and intracellular growth, and modulated IL-6, IL-8, and MIF cytokines that control the cell susceptibility and response against <italic toggle="yes">T. gondii</italic>. Furthermore, we verified that the antiprotozoal activities are not restricted to the presence of the proteolytic domain, and the adhesive domains participate in the control of <italic toggle="yes">T. gondii</italic> infection. Also, by analyzing the structures of Jar and Jar-C through molecular modeling and dynamics, we observed that the adhesive domains in Jar-C are more exposed due to the absence of the proteolytic domain, which could favor the interaction with different targets. Our investigation on the role of SVMP domains in combating <italic toggle="yes">T. gondii</italic> infection highlights their potential application as biotechnological tools for creating more effective treatments for toxoplasmosis.</p></abstract><kwd-group><kwd>toxoplasmosis</kwd><kwd><italic toggle="yes">Toxoplasma gondii</italic></kwd><kwd>snake venom metalloproteinases</kwd></kwd-group><funding-group><award-group><funding-source>Universidade Federal de Uberl&#x000e2;ndia (UFU)</funding-source></award-group><award-group><funding-source>Brazilian funding agencies, Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq)</funding-source><award-id>401907/2023-6</award-id></award-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Minas Gerais (FAPEMIG)</funding-source><award-id>BPD-00271-22</award-id><award-id>APQ-02468-23</award-id></award-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior&#x02014;Brasil (CAPES)</funding-source><award-id>001</award-id></award-group><award-group><funding-source>National Institute of Science and Technology in Theranostics and Nanobiotechnology (INCT-TeraNano)</funding-source></award-group><award-group><funding-source>Center for Bioinformatics and Computational Biology (NBBC) of the Butantan Institute for the High-Performance Computing System</funding-source></award-group><funding-statement>We would like to thank the Universidade Federal de Uberl&#x000e2;ndia (UFU) and the Brazilian funding agencies, Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq) [Grant Number 401907/2023-6] and Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Minas Gerais (FAPEMIG) [Grants Numbers BPD-00271-22; APQ-02468-23]. This study was financed in part by the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior&#x02014;Brasil (CAPES)&#x02014;Finance Code 001, and the National Institute of Science and Technology in Theranostics and Nanobiotechnology (INCT-TeraNano). We thank the Center for Bioinformatics and Computational Biology (NBBC) of the Butantan Institute for the High-Performance Computing System.</funding-statement></funding-group></article-meta><notes notes-type="Key Contribution"><title>Key Contribution</title><p>This work characterized the effects against <italic toggle="yes">T. gondii</italic> of snake venom metalloproteinases from <italic toggle="yes">Bothrops</italic> spp. and the involvement of the protein domains in the control of the infection caused by <italic toggle="yes">T. gondii</italic>.</p></notes></front><body><sec sec-type="intro" id="sec1-toxins-17-00095"><title>1. Introduction</title><p><italic toggle="yes">Toxoplasma gondii</italic> is an obligate intracellular parasite capable of infecting a wide variety of nucleated cells and tissues [<xref rid="B1-toxins-17-00095" ref-type="bibr">1</xref>,<xref rid="B2-toxins-17-00095" ref-type="bibr">2</xref>]. It is estimated that 30 to 50% of the global population is affected by <italic toggle="yes">T. gondii</italic>; the prevalence of this protozoosis may vary according to the region, and these differences are associated with diet, water treatment, intensity of environmental exposure, cultural habits, and socioeconomic factors [<xref rid="B3-toxins-17-00095" ref-type="bibr">3</xref>,<xref rid="B4-toxins-17-00095" ref-type="bibr">4</xref>].</p><p><italic toggle="yes">T. gondii</italic> infection can lead to severe symptoms in immunocompromised individuals and children [<xref rid="B5-toxins-17-00095" ref-type="bibr">5</xref>]. Congenital transmission can be systemic, leading to stillbirth, fetal death, miscarriage, intracranial calcifications, neurological impairments, and ocular conditions [<xref rid="B6-toxins-17-00095" ref-type="bibr">6</xref>,<xref rid="B7-toxins-17-00095" ref-type="bibr">7</xref>]. Congenital toxoplasmosis is a significant public health issue worldwide, including in Brazil, where it is classified as a neglected disease [<xref rid="B8-toxins-17-00095" ref-type="bibr">8</xref>].</p><p>The gold standard treatment for toxoplasmosis involves the combination of sulfadiazine and pyrimethamine; however, adverse effects associated with these drugs include hematological alterations, such as anemia, thrombocytopenia, leukopenia, hypersensitivity reactions, and an increased risk of kidney stones and hepatic complications due to potential bone marrow suppression [<xref rid="B9-toxins-17-00095" ref-type="bibr">9</xref>,<xref rid="B10-toxins-17-00095" ref-type="bibr">10</xref>,<xref rid="B11-toxins-17-00095" ref-type="bibr">11</xref>,<xref rid="B12-toxins-17-00095" ref-type="bibr">12</xref>]. For pregnant women, the use of pyrimethamine has been linked to teratogenic effects and is recommended only after the first trimester of pregnancy [<xref rid="B13-toxins-17-00095" ref-type="bibr">13</xref>,<xref rid="B14-toxins-17-00095" ref-type="bibr">14</xref>]. In addition, numerous studies have demonstrated that <italic toggle="yes">T. gondii</italic> possesses remarkable adaptive potential, leading to the emergence of drug-resistant parasites [<xref rid="B15-toxins-17-00095" ref-type="bibr">15</xref>,<xref rid="B16-toxins-17-00095" ref-type="bibr">16</xref>,<xref rid="B17-toxins-17-00095" ref-type="bibr">17</xref>]. Therefore, the search for more effective and less toxic drugs is necessary for the prevention and treatment of toxoplasmosis.</p><p>In this context, a variety of compounds isolated from natural sources have been used for drug development, due to their prominent biological properties [<xref rid="B18-toxins-17-00095" ref-type="bibr">18</xref>]. Among them, snake venoms have emerged for the development of broad-spectrum therapeutic molecules, as they are composed of a wide variety of biologically active compounds, such as enzymatic and non-enzymatic molecules [<xref rid="B19-toxins-17-00095" ref-type="bibr">19</xref>,<xref rid="B20-toxins-17-00095" ref-type="bibr">20</xref>]. Despite the well-known lethal effects, snake venom toxins exert a variety of prominent effects, such as antimicrobial [<xref rid="B21-toxins-17-00095" ref-type="bibr">21</xref>], antitumor [<xref rid="B22-toxins-17-00095" ref-type="bibr">22</xref>], antiviral [<xref rid="B23-toxins-17-00095" ref-type="bibr">23</xref>,<xref rid="B24-toxins-17-00095" ref-type="bibr">24</xref>], and antiparasitic [<xref rid="B25-toxins-17-00095" ref-type="bibr">25</xref>,<xref rid="B26-toxins-17-00095" ref-type="bibr">26</xref>] activities. These characteristics have increased the interest of many research groups in deeply exploring the structural&#x02013;functional relationship of these bioactive molecules, focusing on its medicinal potential [<xref rid="B18-toxins-17-00095" ref-type="bibr">18</xref>].</p><p>Among the most common and well-studied toxins, snake venom metalloproteinases (SVMPs) have been highlighted. These enzymes are members of the M12B clan of metalloproteinases, which includes the family ADAM (A Disintegrin And Metalloproteinase), and are categorized into three classes (P-I, P-II, and P-III) [<xref rid="B27-toxins-17-00095" ref-type="bibr">27</xref>]. P-I presents a single catalytic metalloproteinase (M) domain dependent on Zn<sup>2+</sup>; P-II comprises an M domain and a disintegrin-like (D) domain; and P-III possesses the M domain, a D domain and a cysteine-rich (C) domain [<xref rid="B27-toxins-17-00095" ref-type="bibr">27</xref>].</p><p>BpMP-I is a P-I SVMP of 20 kDa isolated from <italic toggle="yes">B. pauloensis</italic> snake venom. This toxin is a fibrinogenolytic and anticoagulant metalloproteinase with non-hemorrhagic activities [<xref rid="B28-toxins-17-00095" ref-type="bibr">28</xref>]. Jar is a P-III SVMP composed of 421 amino acids obtained from <italic toggle="yes">B. jararaca</italic> snake venom, with a predicted molecular mass of 47 kDa and an estimated 52 kDa in polyacrylamide gel electrophoresis due to the glycosylation at Asn183 [<xref rid="B29-toxins-17-00095" ref-type="bibr">29</xref>]. Jar-C is a protein of 28 kDa originated from the proteolytic processing of Jar consisting of the D and C domains without known glycosylation sites [<xref rid="B30-toxins-17-00095" ref-type="bibr">30</xref>,<xref rid="B31-toxins-17-00095" ref-type="bibr">31</xref>].</p><p>Bastos and colleagues [<xref rid="B32-toxins-17-00095" ref-type="bibr">32</xref>] pioneeringly reported the anti-<italic toggle="yes">T. gondii</italic> effects of neuwiedase, a P-I metalloproteinase isolated from <italic toggle="yes">Bothrops neuwiedi</italic>, on fibroblast cells, as a model of systemic toxoplasmosis. The authors demonstrated that safe concentrations of neuwiedase impaired both <italic toggle="yes">T. gondii</italic> invasion and replication, as well as modulated the immune response [<xref rid="B32-toxins-17-00095" ref-type="bibr">32</xref>]. In order to gain insights into the underlying antiparasitic activities of SVMPs, BpMP-I (P-I), Jararhagin (P-III), and Jararhagin-C (a disintegrin-like protein) were used to investigate the involvement of the proteolytic and adhesive domains in controlling <italic toggle="yes">T. gondii</italic> infection.</p></sec><sec sec-type="results" id="sec2-toxins-17-00095"><title>2. Results</title><sec id="sec2dot1-toxins-17-00095"><title>2.1. SVMPs Did Not Alter Cell Viability Even at Higher Concentrations</title><p>Firstly, we evaluated the impact of SVMPs on the viability of HeLa cells, treating them with increasing concentrations of BpMP-I, Jar, and Jar-C for 24 h. Any concentration tested (2.5 to 40 &#x000b5;g/mL) did not cause a loss of viability compared to the control group (Ctrl, untreated group) (<xref rid="toxins-17-00095-f001" ref-type="fig">Figure 1</xref>A&#x02013;C).</p></sec><sec id="sec2dot2-toxins-17-00095"><title>2.2. BpMP-I, Jar, and Jar-C Significantly Decreased the Intracellular Proliferation of T. gondii</title><p>To determine the possible effective concentrations against <italic toggle="yes">T. gondii</italic>, we selected the three highest concentrations of each SVMPs (10, 20, and 40 &#x000b5;g/mL) for further antiparasitic assays.</p><p>After the incubation of <italic toggle="yes">T. gondii</italic>-infected cells with SVMPs, our data revealed that BpMP-I (20 and 40 &#x000b5;g/mL; ** <italic toggle="yes">p</italic> &#x0003c; 0.01) and Jar (20 and 40 &#x000b5;g/mL; **** <italic toggle="yes">p</italic> &#x0003c; 0.0001 and *** <italic toggle="yes">p</italic> &#x0003c; 0.001, respectively) were capable of inhibiting parasite growth in host cells in comparison with the control group (Ctrl, <xref rid="toxins-17-00095-f001" ref-type="fig">Figure 1</xref>D,E). Regarding the Jar-C treatment, parasite proliferation was significantly controlled with 40 &#x000b5;g/mL (** <italic toggle="yes">p</italic> &#x0003c; 0.01), when compared to the control group (Ctrl, <xref rid="toxins-17-00095-f001" ref-type="fig">Figure 1</xref>F).</p></sec><sec id="sec2dot3-toxins-17-00095"><title>2.3. SVMP Treatments Differently Modulated the Concentrations of Cytokines</title><p>In the BpMP-I treatment, we observed a reduction in both IL-6 and MIF levels in uninfected HeLa cells compared to the uninfected/untreated cells (* <italic toggle="yes">p</italic> &#x0003c; 0.05); conversely, BpMP-I treatment increased both cytokines production by infected cells in relation to the infected/untreated cells (** <italic toggle="yes">p</italic> &#x0003c; 0.01) (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>A&#x02013;C). <xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>B demonstrates that BpMP-I upregulated the IL-8 release by HeLa cells in comparison to uninfected/untreated (* <italic toggle="yes">p</italic> &#x0003c; 0.05) or infected/untreated (*** <italic toggle="yes">p</italic> &#x0003c; 0.001) cells.</p><p>Regarding Jar treatment, this SVMP strongly downmodulated IL-6 release by HeLa cells in the presence or absence of infection when compared to the uninfected/untreated or infected/untreated cells (*** <italic toggle="yes">p</italic> &#x0003c; 0.001) (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>D). In addition, Jar treatment promoted an augmentation of IL-8 levels in comparison to the uninfected/untreated group (** <italic toggle="yes">p</italic> &#x0003c; 0.01) (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>E). Also, Jar reduced MIF release by HeLa cells in relation to the infected/untreated group (* <italic toggle="yes">p</italic> &#x0003c; 0.05) (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>F).</p><p>Concerning the Jar-C, the toxin decreased both IL-6 and MIF levels in uninfected HeLa cells compared to the uninfected/untreated cells (** <italic toggle="yes">p</italic> &#x0003c; 0.01); similarly, Jar-C downmodulated both IL-6 (**** <italic toggle="yes">p</italic> &#x0003c; 0.0001) and MIF (* <italic toggle="yes">p</italic> &#x0003c; 0.05) production by <italic toggle="yes">T. gondii</italic>-infected cells in relation to the infected/untreated cells (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>G&#x02013;I). In contrast, Jar-C upregulated IL-8 production by HeLa cells in comparison to uninfected/untreated (* <italic toggle="yes">p</italic> &#x0003c; 0.05) or infected/untreated (**** <italic toggle="yes">p</italic> &#x0003c; 0.0001) cells (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>H).</p><p>In <italic toggle="yes">T. gondii</italic> infection, our findings reported that the parasitic infection caused an augmentation of IL-6 (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>A,D,G) and MIF levels (<xref rid="toxins-17-00095-f002" ref-type="fig">Figure 2</xref>C,F,I).</p><p>TNF cytokine was not detected in supernatants under any experimental conditions.</p></sec><sec id="sec2dot4-toxins-17-00095"><title>2.4. Jar and Jar-C Directly Targeted the Host Cell and T. gondii Tachyzoites, Impairing the Establishment of Infection</title><p>Since BpMP-I and Jar (both catalytically active) and Jar-C (catalytically inactive) demonstrated prominent anti-<italic toggle="yes">T. gondii</italic> action, we assessed the ability of Jar or Jar-C to interfere with the early steps of the lytic cycle of the parasite (i.e., adhesion and invasion processes) to gain insights into the involvement of the SVMP domains in the control of <italic toggle="yes">T. gondii</italic> infection. Thus, we promoted both the pretreating of the cells and the parasites before infection. In the first set of experiments, HeLa cells were pretreated with Jar or Jar-C (40 &#x003bc;g/mL) for 30 min or 24 h and then infected with <italic toggle="yes">T. gondii</italic> for 3 h. As observed, the pretreatment of HeLa cells with Jar for 30 min caused a significant reduction in the number of intracellular parasites (** <italic toggle="yes">p</italic> &#x0003c; 0.01) (<xref rid="toxins-17-00095-f003" ref-type="fig">Figure 3</xref>A). Similarly, the pretreatment for 24 h with Jar (** <italic toggle="yes">p</italic> &#x0003c; 0.01) and Jar-C (*** <italic toggle="yes">p</italic> &#x0003c; 0.001) promoted a decrease in the adhered parasites compared to the control group; similarly, both SVMPs diminished the number of intracellular parasites (**** <italic toggle="yes">p</italic> &#x0003c; 0.0001) in comparison to the control group, suggesting a protective effect on HeLa cells (<xref rid="toxins-17-00095-f003" ref-type="fig">Figure 3</xref>B).</p><p>In the second set of experiments, tachyzoites were previously treated with Jar or Jar-C (40 &#x003bc;g/mL) for 30 min before being allowed to interact with HeLa cells. Our results demonstrated that Jar (* <italic toggle="yes">p</italic> &#x0003c; 0.05) and Jar-C (**** <italic toggle="yes">p</italic> &#x0003c; 0.0001) significantly reduced the number of intracellular parasites compared to the untreated parasites (<xref rid="toxins-17-00095-f003" ref-type="fig">Figure 3</xref>C). Representative images highlighting the impact of Jar and Jar-C treatments for 24 h on HeLa cells in the tachyzoites&#x02013;host cell interaction are shown in <xref rid="toxins-17-00095-f003" ref-type="fig">Figure 3</xref>D&#x02013;F.</p></sec><sec id="sec2dot5-toxins-17-00095"><title>2.5. EDTA-Mediated Inhibition of the Proteolytic Activity of BpMP-I and Jar Completely Abolished Their Abilities to Control T. gondii Growth</title><p>Firstly, we demonstrated that the concentration of EDTA (1 mM) used for proteolytic inhibition did not show toxicity against HeLa cells (<xref rid="toxins-17-00095-f004" ref-type="fig">Figure 4</xref>A). As expected, the previous treatment of the catalytically active SVMPs (BpMP-I and Jar) with EDTA (1 mM) caused a strong enzymatic inhibition upon azocasein substrate compared to the crude venom of <italic toggle="yes">B. pauloensis</italic> and <italic toggle="yes">B. jararaca</italic>, respectively, which means that their catalytic sites were successfully inactivated (*** <italic toggle="yes">p</italic> &#x0003c; 0.001) (<xref rid="toxins-17-00095-f004" ref-type="fig">Figure 4</xref>B,C).</p><p>Next, we assessed whether BpMP-I, Jar, or Jar-C would be able to maintain their ability to control parasite intracellular proliferation even in the presence of EDTA. As previously demonstrated, BpMP-I (*** <italic toggle="yes">p</italic> &#x0003c; 0.001), Jar (** <italic toggle="yes">p</italic> &#x0003c; 0.01), and Jar-C (* <italic toggle="yes">p</italic> &#x0003c; 0.05) controlled parasite growth compared to the infected/untreated cells (<xref rid="toxins-17-00095-f004" ref-type="fig">Figure 4</xref>D&#x02013;F). EDTA completely impaired the capacities of BpMP-I (*** <italic toggle="yes">p</italic> &#x0003c; 0.001) and Jar (** <italic toggle="yes">p</italic> &#x0003c; 0.01) in restricting the parasite replication in comparison to the respective toxin-treated group (<xref rid="toxins-17-00095-f004" ref-type="fig">Figure 4</xref>D,E). As expected, Jar-C maintained its anti-<italic toggle="yes">T. gondii</italic> effect even in the presence of EDTA in relation to the control group (untreated cells) (** <italic toggle="yes">p</italic> &#x0003c; 0.01) (<xref rid="toxins-17-00095-f004" ref-type="fig">Figure 4</xref>F), since this toxin is devoid of enzymatic activity.</p></sec><sec id="sec2dot6-toxins-17-00095"><title>2.6. In Silico Analyses Shed Light into the Structure of the Jar and Jar-C</title><p>The primary structure of Jar shares 95.47% of identity with Bothropasin, presenting mutations mainly located in the N-terminal of the M domain. In parallel, Jar-C and Bothropasin share 99.53% of identity, differing by one single amino acid in the N-terminus of Jar-C. Jar is organized in accordance with its template Bothropasin in the M domain (Glu<sup>1</sup>-Asp<sup>209</sup>), D domain (Ile<sup>210</sup>-Lys<sup>302</sup>), and C domain (Asn<sup>303</sup>-Tyr<sup>421</sup>), while Jar-C is formed by the identical D and C domains of Jar and begins at Ile<sup>210</sup>. The MSA can be found in the <xref rid="app1-toxins-17-00095" ref-type="app">Supplementary File S3</xref>.</p><p>The molecular modeling of Jar showed that the D and the C domain form a concave surface toward the M domain (<xref rid="toxins-17-00095-f005" ref-type="fig">Figure 5</xref>A). The M domain of Jar presents a conserved Ca<sup>2+</sup> binding site and three disulfide bonds (Cys<sup>120</sup>-Cys<sup>200</sup>, Cys<sup>160</sup>-Cys<sup>184</sup>, and Cys<sup>162</sup>-Cys<sup>167</sup>) (<xref rid="toxins-17-00095-f005" ref-type="fig">Figure 5</xref>A). The D domain of Jar and Jar-C contains seven disulfide bonds (Cys<sup>216</sup>-Cys<sup>245</sup>, Cys<sup>227</sup>-Cys<sup>240</sup>, Cys<sup>229</sup>-Cys<sup>235</sup>, Cys<sup>239</sup>-Cys<sup>262</sup>, Cys<sup>253</sup>-Cys<sup>259</sup>, Cys<sup>258</sup>-Cys<sup>284</sup>, and Cys<sup>271</sup>-Cys<sup>291</sup>) and two conserved Ca<sup>2+</sup> binding sites (<xref rid="toxins-17-00095-f005" ref-type="fig">Figure 5</xref>A). In addition, this domain accommodates the disintegrin-like loop (Glu<sup>226</sup>-Cys<sup>227</sup>-Asp<sup>228</sup>) (<xref rid="toxins-17-00095-f005" ref-type="fig">Figure 5</xref>A). The C domain of Jar and Jar-C present six disulfide bonds (Cys<sup>303</sup>-Cys<sup>315</sup>, Cys<sup>322</sup>-Cys<sup>372</sup>, Cys<sup>337</sup>-Cys<sup>383</sup>, Cys<sup>350</sup>-Cys<sup>360</sup>, Cys<sup>367</sup>-Cys<sup>409</sup>, and Cys<sup>403</sup>-Cys<sup>414</sup>) (<xref rid="toxins-17-00095-f005" ref-type="fig">Figure 5</xref>A). Despite the lack of the M domain, the D and C domains of Jar-C conserved the C-shaped format, which is reflected by the low RMSD value of 0.022 &#x000c5;. Interestingly, the protein surface inspection showed that in Jar-C, the D and C domains are more exposed given the absence of the M domain (<xref rid="toxins-17-00095-f005" ref-type="fig">Figure 5</xref>B,C).</p><p>Through molecular dynamics, we explored the behavior of Jar and Jar-C and the impact of EDTA on their structures. Although the molecular modeling showed a remarkable similarity between Jar and Jar-C, we noticed that Jar (<xref rid="toxins-17-00095-f006" ref-type="fig">Figure 6</xref>A,B) presents a less dynamic structure than Jar-C (<xref rid="toxins-17-00095-f007" ref-type="fig">Figure 7</xref>A,B). Moreover, despite the fact that Jar-C contains the adhesive domains of Jar, we observed that the D domain was less flexible in Jar (<xref rid="toxins-17-00095-f006" ref-type="fig">Figure 6</xref>C) than in Jar-C (<xref rid="toxins-17-00095-f007" ref-type="fig">Figure 7</xref>C). In fact, the D domain established a scaffold connecting the M and C domains of Jar. The presence of the Ca<sup>2+</sup> ions and the disulfide bonds may contribute to stabilizing the structure of the D and C domains. In parallel, we verified that the simulations with EDTA caused the loss of the Zn<sup>2+</sup> but not the Ca<sup>2+</sup> ions and introduced small variations in the structure of Jar (<xref rid="toxins-17-00095-f006" ref-type="fig">Figure 6</xref>D&#x02013;F) and Jar-C (<xref rid="toxins-17-00095-f007" ref-type="fig">Figure 7</xref>D&#x02013;F). The recordings of molecular dynamics simulations can be found in the <xref rid="app1-toxins-17-00095" ref-type="app">Supplementary Materials</xref>.</p></sec></sec><sec sec-type="discussion" id="sec3-toxins-17-00095"><title>3. Discussion</title><p>Toxoplasmosis is an alarming public health problem with harmful consequences that affects more than one-third of the world&#x02019;s population [<xref rid="B33-toxins-17-00095" ref-type="bibr">33</xref>]. The standard treatment for toxoplasmosis consists of the use of sulfadiazine and pyrimethamine; however, this therapy is often accompanied by adverse side effects [<xref rid="B9-toxins-17-00095" ref-type="bibr">9</xref>,<xref rid="B10-toxins-17-00095" ref-type="bibr">10</xref>,<xref rid="B11-toxins-17-00095" ref-type="bibr">11</xref>,<xref rid="B12-toxins-17-00095" ref-type="bibr">12</xref>,<xref rid="B13-toxins-17-00095" ref-type="bibr">13</xref>,<xref rid="B14-toxins-17-00095" ref-type="bibr">14</xref>]. Therefore, the search for more effective molecules is necessary for the prevention and control of toxoplasmosis.</p><p>Snake venoms have emerged as a valuable source of molecules with pharmacological potential [<xref rid="B34-toxins-17-00095" ref-type="bibr">34</xref>], including antiprotozoal activities [<xref rid="B35-toxins-17-00095" ref-type="bibr">35</xref>]. In this context, this study investigated the effects of three SVMPs (BpMP-I, Jar, and Jar-C) isolated from <italic toggle="yes">Bothrops</italic> spp. snake venoms against <italic toggle="yes">T. gondii</italic> infection in HeLa cells, as well as explored the role of the SVMPs domains in their antiparasitic action.</p><p>Although metalloproteinases represent an important component of viperid venoms, limited attention has been given to their antiparasitic properties [<xref rid="B35-toxins-17-00095" ref-type="bibr">35</xref>]. Nevertheless, a handful of studies have demonstrated the prominent activities against protozoan parasites, such as <italic toggle="yes">P. falciparum</italic> and <italic toggle="yes">T. gondii</italic> [<xref rid="B32-toxins-17-00095" ref-type="bibr">32</xref>,<xref rid="B36-toxins-17-00095" ref-type="bibr">36</xref>,<xref rid="B37-toxins-17-00095" ref-type="bibr">37</xref>,<xref rid="B38-toxins-17-00095" ref-type="bibr">38</xref>].</p><p>To explore the actions of SVMPs against <italic toggle="yes">T. gondii</italic>, we sought to investigate the role of SVMP domains in impairing the early steps of the <italic toggle="yes">T. gondii</italic> lytic cycle. Our findings revealed that the pretreatment of both cells or parasites before infection with Jar and Jar-C compromised the parasite invasion, suggesting that both SVMPs exert their antiparasitic activities by targeting parasites and/or cells in the early stages of infection. Bastos et al. [<xref rid="B32-toxins-17-00095" ref-type="bibr">32</xref>] demonstrated that neuwiedase (P-I SVMP) inhibited <italic toggle="yes">T. gondii</italic> invasion and replication on previously infected host cells or on parasites before fibroblast infection. In our study, we showed that BpMP-I, Jar, and Jar-C restricted <italic toggle="yes">T. gondii</italic> growth in HeLa cells. Noteworthy, the antiparasitic effects of these SVMPs were not exclusively dependent on their proteolytic activity, since Jar-C (catalytically inactive) was also able to impair <italic toggle="yes">T. gondii</italic> intracellular proliferation, suggesting that the adhesive domains participate in the antiparasitic activities.</p><p>In order to assess the possible involvement of the host immune response triggered by the SVMP treatments impairing <italic toggle="yes">T. gondii</italic> infection, we measured the cytokine levels released by HeLa cells. In general, Jar treatment downregulated the release of IL-6 and MIF by infected cells, while BpMP-I upregulated the levels of IL-6, IL-8, and MIF, and Jar-C increased IL-8 production in <italic toggle="yes">T. gondii</italic>-infected cells, which contributed to the reduction in parasite intracellular growth given the role of these cytokines in the control of <italic toggle="yes">T. gondii</italic> proliferation [<xref rid="B39-toxins-17-00095" ref-type="bibr">39</xref>,<xref rid="B40-toxins-17-00095" ref-type="bibr">40</xref>,<xref rid="B41-toxins-17-00095" ref-type="bibr">41</xref>,<xref rid="B42-toxins-17-00095" ref-type="bibr">42</xref>].</p><p>Clissa et al. (2001) [<xref rid="B43-toxins-17-00095" ref-type="bibr">43</xref>] reported that Jar positively regulates the IL-1&#x003b2;, IL-6, and TNF-&#x003b1; expression at the transcriptional levels, but not at the protein level. Furthermore, the authors demonstrated that Jar degraded soluble cytokines by proteolytic activity. In parallel, Silva et al. (2016) [<xref rid="B44-toxins-17-00095" ref-type="bibr">44</xref>] showed that BooMP-Alpha-I, a P-I SVMP from <italic toggle="yes">Bothrops moojeni</italic>, promoted the direct proteolysis of TNF, indicating that zinc metalloproteinases can modulate TNF levels. Hence, the negative regulation of IL-6 mediated by Jar treatment in HeLa cells could be a consequence of the proteolytic action; nevertheless, to validate this hypothesis, further studies need to be thoroughly evaluated.</p><p>Taken together, BpMP-I, Jar, and Jar-C differently modulated the levels of IL-8, MIF, and IL-6, which are cytokines associated with the host cell susceptibility to <italic toggle="yes">T. gondii</italic> infection [<xref rid="B45-toxins-17-00095" ref-type="bibr">45</xref>,<xref rid="B46-toxins-17-00095" ref-type="bibr">46</xref>,<xref rid="B47-toxins-17-00095" ref-type="bibr">47</xref>,<xref rid="B48-toxins-17-00095" ref-type="bibr">48</xref>,<xref rid="B49-toxins-17-00095" ref-type="bibr">49</xref>]. It is worth mentioning that although Jar-C possesses the identical disintegrin-like and cysteine-rich domains of Jar, the cytokine levels were differently modulated.</p><p>Jar belongs to the P-III class of SVMPs and presents multiple effects associated with the D and C domains [<xref rid="B50-toxins-17-00095" ref-type="bibr">50</xref>,<xref rid="B51-toxins-17-00095" ref-type="bibr">51</xref>,<xref rid="B52-toxins-17-00095" ref-type="bibr">52</xref>]. The M domain of P-III SVMPs is involved in the proteolysis of extracellular components, the processing of cytokines, and the shedding of integrins from cell surfaces [<xref rid="B50-toxins-17-00095" ref-type="bibr">50</xref>,<xref rid="B51-toxins-17-00095" ref-type="bibr">51</xref>,<xref rid="B52-toxins-17-00095" ref-type="bibr">52</xref>]. Due to differences in effects among P-III SVMPs, it is proposed that the D and C domains also play important roles in biological effects [<xref rid="B50-toxins-17-00095" ref-type="bibr">50</xref>,<xref rid="B51-toxins-17-00095" ref-type="bibr">51</xref>,<xref rid="B52-toxins-17-00095" ref-type="bibr">52</xref>]. Despite the absence of the M domain, Jar-C possesses relevant activities, including the inhibition of collagen-induced platelet aggregation [<xref rid="B30-toxins-17-00095" ref-type="bibr">30</xref>], proinflammatory effects [<xref rid="B53-toxins-17-00095" ref-type="bibr">53</xref>], leukocyte recruitment [<xref rid="B54-toxins-17-00095" ref-type="bibr">54</xref>,<xref rid="B55-toxins-17-00095" ref-type="bibr">55</xref>], and binding to the basement membrane collagens within the vascular lesion [<xref rid="B56-toxins-17-00095" ref-type="bibr">56</xref>].</p><p>To gain insights into the role of the proteolytic domain in controlling <italic toggle="yes">T. gondii</italic> infection, we preincubated BpMP-I, Jar, and Jar-C with EDTA, a chelator of divalent cation. The EDTA-mediated inhibition of the catalytic activity of BpMP-I and Jar completely abolished their ability to regulate the parasite intracellular proliferation. Therefore, the anti-<italic toggle="yes">T. gondii</italic> effects of both BpMP-I and Jar are probably dependent on the catalytic mechanism. In parallel, Jar-C continued impairing the parasite growth even in the presence of EDTA, pointing out that the D and C domains of this SVMP are involved in their antiprotozoal effect.</p><p>It has been previously shown that the inhibition of the catalytic activity of Jar is not sufficient to abolish its effects, highlighting that the disintegrin-like/cysteine-rich domains are able to interact with host cell components, triggering biological effects [<xref rid="B51-toxins-17-00095" ref-type="bibr">51</xref>]. Since the D and C domains of Jar-C are also present in Jar, we raised the following question: why is it that it did not maintain its antiparasitic effect in the presence of EDTA? In this intriguing scenario, we further employed in silico analyses with Jar and Jar-C (with or without EDTA) to shed light on the differences in the anti-<italic toggle="yes">T. gondii</italic> activities.</p><p>The tertiary structure of Jar showed that the protein conserves the C-shaped format of P-III SVMPs, similarly to Bothropasin [<xref rid="B30-toxins-17-00095" ref-type="bibr">30</xref>]. In parallel, despite the lack of the M domain, Jar-C maintained the D and C domains in the C-shaped conformation, which may be stabilized by the conserved disulfide bonds and Ca<sup>2+</sup> ions [<xref rid="B30-toxins-17-00095" ref-type="bibr">30</xref>]. In addition, through molecular modeling and dynamics, we observed that, due to the absence of the catalytic domain, the D and C domains of Jar-C are more exposed. These adhesive domains present conserved protein&#x02013;protein interaction sites among different SVMPs, which mediates the binding of molecular targets involved in their biological activities, including fibronectin, vWF (von Willebrand factor), and integrins [<xref rid="B57-toxins-17-00095" ref-type="bibr">57</xref>,<xref rid="B58-toxins-17-00095" ref-type="bibr">58</xref>,<xref rid="B59-toxins-17-00095" ref-type="bibr">59</xref>,<xref rid="B60-toxins-17-00095" ref-type="bibr">60</xref>,<xref rid="B61-toxins-17-00095" ref-type="bibr">61</xref>,<xref rid="B62-toxins-17-00095" ref-type="bibr">62</xref>]. Interestingly, <italic toggle="yes">T. gondii</italic>&#x02019;s ability to invade host cells involves an attachment to integrin receptors [<xref rid="B63-toxins-17-00095" ref-type="bibr">63</xref>,<xref rid="B64-toxins-17-00095" ref-type="bibr">64</xref>,<xref rid="B65-toxins-17-00095" ref-type="bibr">65</xref>], which could be a target involved in the anti-<italic toggle="yes">T. gondii</italic> effects mediated by SVMPs. In view of the differences in the structures and effects of Jar and Jar-C, we suggest that the accessibility of the domains may impact the binding to distinct targets, triggering different mechanisms of action in the control of the <italic toggle="yes">T. gondii</italic> infection. Moreover, as glycosylation is a major protein modification of snake venom toxins and plays important roles in their structures and activities [<xref rid="B66-toxins-17-00095" ref-type="bibr">66</xref>,<xref rid="B67-toxins-17-00095" ref-type="bibr">67</xref>,<xref rid="B68-toxins-17-00095" ref-type="bibr">68</xref>,<xref rid="B69-toxins-17-00095" ref-type="bibr">69</xref>,<xref rid="B70-toxins-17-00095" ref-type="bibr">70</xref>,<xref rid="B71-toxins-17-00095" ref-type="bibr">71</xref>,<xref rid="B72-toxins-17-00095" ref-type="bibr">72</xref>,<xref rid="B73-toxins-17-00095" ref-type="bibr">73</xref>,<xref rid="B74-toxins-17-00095" ref-type="bibr">74</xref>,<xref rid="B75-toxins-17-00095" ref-type="bibr">75</xref>], this important post-translational modification (PTM) could influence the activity of the toxins studied, as Jar is known to be glycosylated at the proteolytic domain, and Jar-C lacks predicted glycosylation sites [<xref rid="B30-toxins-17-00095" ref-type="bibr">30</xref>,<xref rid="B31-toxins-17-00095" ref-type="bibr">31</xref>].</p><p>The use of metal chelators contributes to the understanding of the behavior of the SVMP domains and to the development of more effective therapeutic agents [<xref rid="B76-toxins-17-00095" ref-type="bibr">76</xref>]. EDTA not only inhibits the enzymatic activity of SVMPs but can alter the structure by producing aggregates and introducing structural alterations [<xref rid="B77-toxins-17-00095" ref-type="bibr">77</xref>,<xref rid="B78-toxins-17-00095" ref-type="bibr">78</xref>,<xref rid="B79-toxins-17-00095" ref-type="bibr">79</xref>,<xref rid="B80-toxins-17-00095" ref-type="bibr">80</xref>]. Interestingly, Zychar et al. [<xref rid="B54-toxins-17-00095" ref-type="bibr">54</xref>] verified that 1,10-phenanthroline (oPhe), a zinc chelator, caused enzymatic inactivation and structural modifications of Jar without preventing the binding to collagen, pointing out that the M domain is essential for Jar activity, as the inactivated enzyme did not promote leukocyte&#x02013;endothelial cell interactions [<xref rid="B54-toxins-17-00095" ref-type="bibr">54</xref>]. Also, the authors verified that, despite the absence of the M domain, Jar-C had an effect on the cellular interactions, indicating that the D or the C domain could also participate in inflammatory responses [<xref rid="B54-toxins-17-00095" ref-type="bibr">54</xref>]. In view of this, the absence of the antiparasitic activity of Jar in the presence of EDTA could be partially explained due to the enzymatic inactivation of the M domain, while Jar-C maintained the anti-<italic toggle="yes">T. gondii</italic> effect through the D and C domains.</p><p>Taken together, Jar and Jar-C may interact with different targets in <italic toggle="yes">T. gondii</italic>, triggering distinct mechanisms of action. In Jar, the D and/or C domains may be involved in the substrate recognition for the proteolytic action of the M domain. In Jar-C, the absence of the catalytic domain makes the adhesive domains more accessible and may facilitate interactions with distinct targets. Given their prominent antiparasitic effects, a better comprehension of the functional role of each domain in the control of <italic toggle="yes">T. gondii</italic> infection would corroborate the use of these toxins as biotechnological tools for the selection of molecular targets, helping the development of alternative approaches for the treatment of toxoplasmosis.</p></sec><sec sec-type="conclusions" id="sec4-toxins-17-00095"><title>4. Conclusions</title><p>In summary, we assessed the anti-<italic toggle="yes">T. gondii</italic> effects of three SVMPs (BpMP-I, Jar, and Jar-C) from <italic toggle="yes">Bothrops</italic> spp. These toxins impaired both the <italic toggle="yes">T. gondii</italic> invasion and intracellular proliferation, as well as modulated different key cytokines involved in the control of <italic toggle="yes">T. gondii</italic> infection. Moreover, we demonstrated that the effects are not fully dependent on the proteolytic action, and the adhesive domains are also involved in the antiprotozoal activity. Our results corroborate the potential use of SVMPs as a biotechnological tool for the search of more effective and less toxic molecules against toxoplasmosis.</p></sec><sec id="sec5-toxins-17-00095"><title>5. Materials and Methods</title><sec id="sec5dot1-toxins-17-00095"><title>5.1. Venoms and Toxins</title><p><italic toggle="yes">Bothrops</italic> crude venoms were collected from snakes kept at the CETA (Animal Toxin Extraction Center Ltd.a.&#x02014;CNPJ: 08.972.260/0001-30, Morungaba, SP, Brazil), which has received IBAMA registration and approval for the use of renewable natural resources (n&#x000b0; 2087163). BpMP-I was supplied by the Biochemistry and Animal Toxins laboratory at the Federal University of Uberl&#x000e2;ndia. The toxin was purified from freeze-dried <italic toggle="yes">B. pauloensis</italic> venom according to Naves de Souza et al. (2012) [<xref rid="B28-toxins-17-00095" ref-type="bibr">28</xref>].</p><p>Jararhagin (Jar) and Jararhagin-C (Jar-C) were purified from the freeze-dried venom of <italic toggle="yes">Bothrops jararaca</italic>, supplied by the Herpetology Laboratory at the Butantan Institute (S&#x000e3;o Paulo, SP, Brazil). The purification was carried out as described by Ferreira et al. (2018) [<xref rid="B49-toxins-17-00095" ref-type="bibr">49</xref>]. Protein concentration was measured using Bradford assay [<xref rid="B81-toxins-17-00095" ref-type="bibr">81</xref>]. The analysis of protein purity was evaluated by SDS-PAGE electrophoresis (<xref rid="app1-toxins-17-00095" ref-type="app">Supplementary File S1</xref>) under denaturing conditions, with minor modifications [<xref rid="B82-toxins-17-00095" ref-type="bibr">82</xref>]. In brief, the 12.5% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) gel for BpMP-I and the 15% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) gel for Jar and Jar-C were prepared using the Hoefer SE 260 Mighty Small II Mini-Vertical electrophoresis system (Bridgewater, MA, USA). The samples were dispersed in 0.06 M Tris-HCl (LGC Biotecnologia, SP, Brazil) pH 6.8, 0.01% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) bromophenol blue (Vetec Quimica Fina Ltda., SP, Brazil), 10% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) glycerol (Synth, SP, Brazil), and 20% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) &#x003b2;-mercaptoethanol (Sigma Chemical Co., St. Louis, MO, USA). After the run, the gels were stained with a 0.1% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) Coomassie Brilliant Blue R-250 (Sigma) solution in a 1:1 (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) water and ethanol mixture and destained with a 7% acetic acid solution (L.S. Chemicals, Mumbai, Maharashtra, India).</p></sec><sec id="sec5dot2-toxins-17-00095"><title>5.2. Cell Culture and Parasite Maintenance</title><p>Human uterine cervical (HeLa) cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in 25 cm<sup>2</sup> flasks containing RPMI 1640 medium, supplemented with 100 U/mL of penicillin, 100 &#x003bc;g/mL of streptomycin (Sigma), and 10% fetal bovine serum (FBS) (Cultilab, Campinas, SP, Brazil). The cells were maintained in a humidified incubator at 37 &#x000b0;C with 5% CO<sub>2</sub>, as previously described [<xref rid="B39-toxins-17-00095" ref-type="bibr">39</xref>].</p><p><italic toggle="yes">T. gondii</italic> tachyzoites (2F1 clone) constitutively expressing the &#x003b2;-galactosidase gene and derived from the highly virulent RH strain were given by Dr. Vern Carruthers, from the School of Medicine at the University of Michigan (USA). The parasites were maintained by serial passages in HeLa cells cultured in medium containing 2% FBS, 100 U/mL of penicillin and 100 mg/mL of streptomycin at the same described conditions [<xref rid="B39-toxins-17-00095" ref-type="bibr">39</xref>].</p></sec><sec id="sec5dot3-toxins-17-00095"><title>5.3. Cellular Viability</title><p>The effect of each SVMPs on HeLa cells viability was assessed by the tetrazolium salt colorimetric (MTT) assay [<xref rid="B83-toxins-17-00095" ref-type="bibr">83</xref>]. HeLa cells were seeded at 3 &#x000d7; 10<sup>4</sup> cell/well in 100 &#x003bc;L of RPMI 1640 medium with 10% FBS in 96-well microplates. After adhesion, cells were treated for 24 h at 37 &#x000b0;C with twofold serial dilutions of BpMP-I, Jar, and Jar-C (ranging from 40 to 2.5 &#x003bc;g/mL). Only culture medium was used as a positive control of viability, and these cells were considered to be 100% viable. Next, the supernatants were removed and the cells were incubated with MTT reagent (5 mg/mL, 10 &#x003bc;L) (Sigma) plus 90 &#x003bc;L of supplemented RPMI medium for 3 h followed by the addition of 10% sodium dodecyl sulfate (SDS, Sigma) and 50% N,N-dimethylformamide (Sigma). MTT reduction was measured at 570 nm absorbance, and the cell viability was reported in percentages (cell viability %).</p></sec><sec id="sec5dot4-toxins-17-00095"><title>5.4. T. gondii Intracellular Proliferation Assay</title><p>The &#x003b2;-galactosidase colorimetric assay was used to assess BpMP-I, Jar, and Jar-C effects on <italic toggle="yes">T. gondii</italic> intracellular proliferation in HeLa cells, as previously described [<xref rid="B84-toxins-17-00095" ref-type="bibr">84</xref>]. In brief, HeLa cells were plated at 3 &#x000d7; 10<sup>4</sup> cells/well in 96-well microplates and incubated overnight at 37 &#x000b0;C and 5% CO<sub>2</sub>. After the adhesion, cells were infected with <italic toggle="yes">T. gondii</italic> tachyzoites at a multiplicity of infection (MOI) of 3:1 in supplemented RPMI medium with 2% of FBS for 3 h. Then, cells were rinsed with 1&#x000d7; PBS (Sigma) in order to remove the excess of extracellular parasites. Based on MTT assay, we treated the <italic toggle="yes">T. gondii</italic>-infected HeLa cells for 24 h at 37 &#x000b0;C with 10, 20, and 40 &#x003bc;g/mL of each SVMP as the highest non-cytotoxic doses for host cells. The classic combination of sulfadiazine (SDZ, Sigma) and pyrimethamine (PYR, Sigma) was used as a positive control for parasite control. The concentration of SDZ (200 &#x003bc;g/mL) + PYR (8 &#x003bc;g/mL) used was based on a previously published work [<xref rid="B85-toxins-17-00095" ref-type="bibr">85</xref>]. In parallel, culture supernatants were collected and stored at &#x02212;80 &#x000b0;C for the further measurement of cytokines. <italic toggle="yes">T. gondii</italic> intracellular proliferation was screened based on &#x003b2;-galactosidase activity using the chlorophenol red-&#x003b2;-D-galactopyranoside reagent substrate (CPRG; Roche Diagnostics, Mannheim, Germany). In brief, infected HeLa cells were lysed with 100 &#x003bc;L of ice-cold lysis buffer (100 mM of HEPES, pH 8.0, 1 mM of MgSO<sub>4</sub>, 0.1% Triton X-100, and 5 mM of dithiothreitol) (Sigma), and mixed with 160 &#x003bc;L of assay buffer (100 mM of phosphate buffer, pH 7.3, 102 of mM &#x003b2;-mercaptoethanol, and 9 mM of MgCl<sub>2</sub>) (Sigma) and 40 &#x003bc;L of 3.125 mM of CPRG. The number of tachyzoites was obtained according to a reference curve containing free tachyzoites (ranging from 1 &#x000d7; 10<sup>6</sup> to 15.6 &#x000d7; 10<sup>3</sup>) and data were expressed as percentage of <italic toggle="yes">T. gondii</italic> proliferation (% of <italic toggle="yes">T. gondii</italic> proliferation) in each treatment condition compared to control (infected/untreated cells), which corresponded to 100% of parasite proliferation [<xref rid="B85-toxins-17-00095" ref-type="bibr">85</xref>].</p></sec><sec id="sec5dot5-toxins-17-00095"><title>5.5. Cytokine Measurement</title><p>The release of cytokines in the supernatants of HeLa cells was measured using a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). Assays for IL-6, IL-8, TNF (OpTEIA, BD Biosciences, San Diego, CA, USA), and MIF (Duoset R&#x00026;D Systems, Minneapolis, MN, USA) were conducted following the manufacturer&#x02019;s instructions. Cytokine measurement was made at 450 nm absorbance with a multi-well scanning spectrophotometer (Titertek Multiskan Plus, Flow Laboratories, McLean, VA, USA), following a previously published work [<xref rid="B85-toxins-17-00095" ref-type="bibr">85</xref>]. Cytokine concentrations were reported in pg/mL. The detection limits for each cytokine were determined from standard curves: IL-6 (4.7 pg/mL), IL-8 (31.2 pg/mL), TNF (7.8 pg/mL), and MIF (7.8 pg/mL).</p></sec><sec id="sec5dot6-toxins-17-00095"><title>5.6. Invasion and Attachment Assay</title><p>To investigate whether SVMPs act directly on parasites or host cells, impairing early steps of <italic toggle="yes">T. gondii</italic> infection, an invasion and attachment assay was performed as previously described [<xref rid="B26-toxins-17-00095" ref-type="bibr">26</xref>], with minor modifications. HeLa cells were seeded at a density of 1.0 &#x000d7; 10<sup>5</sup> in 24-well microplates containing 13 mm coverslips. In the first set of experiments, to investigate the possible protective effect of toxins on host cells, HeLa cells were pretreated for 30 min or 24 h at 37 &#x000b0;C and 5% CO<sub>2</sub> with the culture medium (control group), Jar, or Jar-C (both 40 &#x003bc;g/mL). Next, the treatments were removed and parasites (MOI of 3:1) were allowed to interact with cells for 3 h at 37 &#x000b0;C and 5% CO<sub>2</sub>.</p><p>In the second set of experiments, we assessed the possible direct action of SVMPs on parasites. <italic toggle="yes">T. gondii</italic> tachyzoites (3:1) were added to microtubes and treated for 30 min at 37 &#x000b0;C and 5% CO<sub>2</sub> with the culture medium (control group), Jar, or Jar-C (both 40 &#x003bc;g/mL). After that, parasites were centrifuged, resuspended in a treatment-free medium, and placed in 96-well microplates containing adhered HeLa cells (1.0 &#x000d7; 10<sup>5</sup> cells) for 3 h at 37 &#x000b0;C and 5% CO<sub>2</sub>.</p><p>At the end of both experimental procedures mentioned above, cells were carefully rinsed with 1&#x000d7; PBS (Thermo Fisher Scientific, IL, USA) to remove the excess of non-invaded parasites and then fixed with 4% paraformaldehyde (PFA) (Fluka Chemika, Buchs, St. Gallen, Switzerland) for 12 min at room temperature. For labeling, fixed cells were submitted to rabbit polyclonal primary anti-<italic toggle="yes">T. gondii</italic> antibody (Abcam #20530; Waltham, MA, USA) [diluted 1:500 in PGN (PBS containing 0.25% gelatin)] for 1 h, followed by Alexa Fluor 594-conjugated anti-rabbit IgG (Invitrogen, USA #A11012; Waltham, MA, USA), also diluted 1:500 in PGN. Similarly, cells were incubated with rabbit polyclonal primary anti-<italic toggle="yes">T. gondii</italic> antibody (diluted 1:500 in PGN-0.01% saponin-permeabilizing solution, Sigma) for 1 h, followed by incubation for 1 h with Alexa Fluor 488-conjugated anti-rabbit IgG (Invitrogen, USA #A11008; Waltham, MA, USA), and the cell nucleus marker DAPI, both diluted in PGN + saponin. Finally, we mounted coverslips on glass slides, and samples were analyzed by confocal fluorescence microscopy (Zeiss, LSM 510 Meta, Oberkochen, Baden-W&#x000fc;rttemberg, Germany) with an inverted microscope (Zeiss Axiovert 200 M). The number of intracellular (green<sup>+</sup>/red<sup>&#x02212;</sup>) and adhered [red or red<sup>+</sup>/green<sup>+</sup> (yellow)] parasites was scored on 20 randomly selected fields on each separately mounted coverslip. We normalized the data by the ratio (number of parasites/cell nucleus) of each experimental condition.</p></sec><sec id="sec5dot7-toxins-17-00095"><title>5.7. Azocaseinolytic Activity</title><p>Before assessing the maintenance of the antiparasitic action of the SVMPs after inhibiting with the protease inhibitor EDTA (Sigma), we further confirmed the enzymatic inhibition of EDTA by testing the azocaseinolytic activity of toxins upon the azocasein substrate, as previously published [<xref rid="B86-toxins-17-00095" ref-type="bibr">86</xref>]. Briefly, BpMP-I and Jar (5 &#x003bc;g)&#x02014;both with enzymatic activity&#x02014;were preincubated with 10 &#x003bc;L of EDTA (1 mM) for 1 h at 37 &#x000b0;C. As control, we also used the crude venoms (5 &#x003bc;g) of <italic toggle="yes">B. pauloensis</italic> and <italic toggle="yes">B. jararaca</italic>. Afterwards, 45 &#x003bc;L of this solution was incubated at 37 &#x000b0;C and 5% CO<sub>2</sub> with 100 &#x003bc;L of azocasein (1 mg/mL) (Sigma) in 0.05 M Tris-HCl and 0.15 M NaCl (LGC Biotecnologia, SP, Brazil) in 96-well microplates. After 30 min, the reaction was stopped by adding 45 &#x003bc;L of trichloroacetic acid 20% (<italic toggle="yes">m</italic>/<italic toggle="yes">v</italic>) in each sample, which was incubated at room temperature for an additional 30 min and then centrifuged at 3000&#x000d7; <italic toggle="yes">g</italic> for 20 min (Eppendorf 5430R, Hamburg, Barkhausenweg, Germany). The absorbance of the supernatant was measured at 366 nm with a multi-well scanning spectrophotometer (Multiskan GO, Thermo). One unit (U) of azocaseinolytic activity was defined as an increase of 0.01 absorbance units per minute.</p></sec><sec id="sec5dot8-toxins-17-00095"><title>5.8. Analysis of the Influence of the Catalytic Activity of SVMPs on Impairing T. gondii Growth</title><p>To gain insights into the role of the catalytic activity of SVMPs in triggering their anti-<italic toggle="yes">T. gondii</italic> effect, we preincubated or not 40 &#x003bc;g/mL of BpMP-I, Jar, and Jar-C for 1 h at 37 &#x000b0;C with EDTA (1 mM). In parallel, adhered HeLa cells (3 &#x000d7; 10<sup>4</sup>/96-well microplate) were infected for 3 h at 37 &#x000b0;C with <italic toggle="yes">T. gondii</italic> tachyzoites (MOI of 3:1) and then treated for 24 h at 37 &#x000b0;C and 5% CO<sub>2</sub> with the toxins preincubated with EDTA. As controls, infected cells were incubated with culture medium only, EDTA (1 mM), or SVMPs (40 &#x003bc;g/mL without EDTA pretreatment). <italic toggle="yes">T. gondii</italic> intracellular proliferation was carried out as described above (see item 5.4).</p></sec><sec id="sec5dot9-toxins-17-00095"><title>5.9. Molecular Modeling and Multiple Sequence Alignment</title><p>We performed a bioinformatics analysis to investigate the structure&#x02013;function relationship of Jar and Jar-C and gain insights into the involvement of the protein domains in the control of <italic toggle="yes">T. gondii</italic> infection. The tertiary structures of Jar and Jar-C were built by homology modeling using SWISS-MODEL [<xref rid="B87-toxins-17-00095" ref-type="bibr">87</xref>]. Briefly, the sequences of Jar (UniProt/SwissProt [<xref rid="B88-toxins-17-00095" ref-type="bibr">88</xref>]: P30431) and Jar-C [<xref rid="B30-toxins-17-00095" ref-type="bibr">30</xref>] were modeled using, as a template, the structure of Bothropasin [<xref rid="B89-toxins-17-00095" ref-type="bibr">89</xref>] (PDB [<xref rid="B90-toxins-17-00095" ref-type="bibr">90</xref>]: 3DSL) from <italic toggle="yes">B. jararaca</italic>. The protein models were refined using MolProbity [<xref rid="B91-toxins-17-00095" ref-type="bibr">91</xref>], and QMEANDisCo [<xref rid="B92-toxins-17-00095" ref-type="bibr">92</xref>] and ERRAT [<xref rid="B93-toxins-17-00095" ref-type="bibr">93</xref>] were used to assess the stereochemical quality (<xref rid="app1-toxins-17-00095" ref-type="app">Supplementary File S2</xref>) in SAVES v.6.0 (<uri xlink:href="https://saves.mbi.ucla.edu/">https://saves.mbi.ucla.edu/</uri>) (accessed on 27 February 2024). Subsequently, the three-dimensional structures of Jar and Jar-C were analyzed in PyMOL v. 2.5 (Schr&#x000f6;dinger, Inc., New York, NY, USA), and the electrostatic surface was determined using the plugin APBS Electrostatics [<xref rid="B94-toxins-17-00095" ref-type="bibr">94</xref>]. In addition, to verify the similarities between the sequences of Jar, Jar-C, and Bothropasin, a Multiple Sequence Alignment (MSA) was performed using Clustal Omega v. 1.4.2 [<xref rid="B95-toxins-17-00095" ref-type="bibr">95</xref>] and visualized using the package pyMSAviz [<xref rid="B96-toxins-17-00095" ref-type="bibr">96</xref>].</p></sec><sec id="sec5dot10-toxins-17-00095"><title>5.10. Molecular Dynamics</title><p>We performed molecular dynamics simulations to further explore the structures of Jar and Jar-C and the effect of EDTA in their structures. The 3D structure of EDTA was obtained from PubChem [<xref rid="B97-toxins-17-00095" ref-type="bibr">97</xref>] under accession code 6049. The protonation states of EDTA at a pH of 7.4 were corrected using Avogadro v. 1.2.0 [<xref rid="B98-toxins-17-00095" ref-type="bibr">98</xref>], and the protein protonation states were corrected with AMBER in APBS [<xref rid="B99-toxins-17-00095" ref-type="bibr">99</xref>]. MD simulations were performed in GROMACS v. 2022 [<xref rid="B100-toxins-17-00095" ref-type="bibr">100</xref>]. The parametrization of EDTA was performed using ACPYPE [<xref rid="B101-toxins-17-00095" ref-type="bibr">101</xref>], and the proteins were parameterized using AMBER99SB [<xref rid="B102-toxins-17-00095" ref-type="bibr">102</xref>]. The systems were simulated in a cubic box with 1.5 nm of limits in any dimension and filled with TIP3P water molecules [<xref rid="B103-toxins-17-00095" ref-type="bibr">103</xref>]. The systems were neutralized by applying Na<sup>+</sup> and Cl<sup>&#x02212;</sup> counterions. Then, a two-step energy minimization was performed using steepest descent and conjugate gradient algorithms. Next, atomic velocities were assigned using a Maxwell&#x02013;Boltzmann distribution, and the systems were gradually heated to 300 K with a velocity-rescaling thermostat (V-rescale). Subsequently, an equilibration of pressure was conducted using the Parrinello&#x02013;Rahman barostat to 1 atm. Afterwards, four MD productions were performed in three independent simulations each of 200 ns: (i) Jar; (ii) Jar-C; (ii) Jar + EDTA; and (iv) Jar-C + EDTA. The Root Mean Square Fluctuation (RMSF) was calculated fitting the C-alpha atoms, while the Root Mean Square Deviation (RMSD) and the radius of gyration were calculated fitting the backbone. The hydrogen bonds were calculated considering a maximum distance of 3.5 &#x000c5; between donor and acceptor, and a maximum angle of 30&#x000b0; between donor, donor&#x02013;hydrogen, and acceptor. The trajectories were analyzed and visualized using VMD (Visual Molecular Dynamics) v. 1.9.3 [<xref rid="B104-toxins-17-00095" ref-type="bibr">104</xref>], and the images were generated in PyMOL v.2.5 (Schr&#x000f6;dinger, Inc., NY, USA).</p></sec><sec id="sec5dot11-toxins-17-00095"><title>5.11. Statistical Analysis</title><p>Data were expressed as mean &#x000b1; standard error of the mean (&#x000b1;SEM) using GraphPad Prism version 8.01. Significant differences were compared to controls by using one-way ANOVA. The parametric data were analyzed by Bonferroni&#x02019;s multiple comparisons post-test and the Kruskal&#x02013;Wallis test and Tukey&#x02019;s multiple comparison post-test for non-parametric. Values of <italic toggle="yes">p</italic> &#x0003c; 0.05 were considered statistically significant.</p></sec></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-toxins-17-00095"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/toxins17020095/s1">https://www.mdpi.com/article/10.3390/toxins17020095/s1</uri>, Supplementary File S1. SDS-PAGE. Supplementary File S2. Quality assessment of Jar and Jar-C structures. Supplementary File S3. Multiple Sequence Alignment (MSA). Supplementary File S4. Molecular dynamics of Jar. Supplementary File S5. Molecular dynamics of Jar with EDTA. Supplementary File S6. Molecular dynamics of Jar-C. Supplementary File S7. Molecular dynamics of Jar-C with EDTA.</p><supplementary-material id="toxins-17-00095-s001" position="float" content-type="local-data"><media xlink:href="toxins-17-00095-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, S.C.T., D.S.L., P.B.C., B.F.B., E.A.V.F. and V.d.M.R.&#x000c1;.; Formal Analysis, S.C.T., T.A.M.F., V.C.d.S. and M.Y.N.-J.; Funding Acquisition, B.F.B., E.A.V.F. and V.d.M.R.&#x000c1;.; Investigation, S.C.T., G.d.S., L.C.L., M.P., J.P.d.L.J., A.M.R., A.F.F.M., V.d.F. and P.B.C.; Methodology, S.C.T. and T.A.M.F.; Project Administration, E.A.V.F. and V.d.M.R.&#x000c1;.; Validation, S.C.T.; Writing&#x02014;Original Draft, S.C.T. and T.A.M.F.; Writing&#x02014;Review and Editing, S.C.T., T.A.M.F., G.d.S., L.C.L., M.P., J.P.d.L.J., B.F.B., E.A.V.F. and V.d.M.R.&#x000c1;. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in this article and <xref rid="app1-toxins-17-00095" ref-type="app">Supplementary Material</xref>. Further inquiries can be directed to the corresponding authors.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-17-00095"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>J.P.</given-names></name>
<name><surname>Lago</surname><given-names>E.G.</given-names></name>
<name><surname>Gennari</surname><given-names>S.M.</given-names></name>
<name><surname>Su</surname><given-names>C.</given-names></name>
<name><surname>Jones</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Toxoplasmosis in humans and animals in Brazil: High prevalence, high burden of disease, and epidemiology</article-title><source>Parasitology</source><year>2012</year><volume>139</volume><fpage>1375</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1017/S0031182012000765</pub-id><pub-id pub-id-type="pmid">22776427</pub-id>
</element-citation></ref><ref id="B2-toxins-17-00095"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Montoya</surname><given-names>J.G.</given-names></name>
<name><surname>Liesenfeld</surname><given-names>O.</given-names></name>
</person-group><article-title>Toxoplasmosis</article-title><source>Lancet</source><year>2004</year><volume>363</volume><fpage>1965</fpage><lpage>1976</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16412-X</pub-id><pub-id pub-id-type="pmid">15194258</pub-id>
</element-citation></ref><ref id="B3-toxins-17-00095"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flegr</surname><given-names>J.</given-names></name>
<name><surname>Prandota</surname><given-names>J.</given-names></name>
<name><surname>Sovi&#x0010d;kov&#x000e1;</surname><given-names>M.</given-names></name>
<name><surname>Israili</surname><given-names>Z.H.</given-names></name>
</person-group><article-title>Toxoplasmosis&#x02014;A global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e90203</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0090203</pub-id><pub-id pub-id-type="pmid">24662942</pub-id>
</element-citation></ref><ref id="B4-toxins-17-00095"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pappas</surname><given-names>G.</given-names></name>
<name><surname>Roussos</surname><given-names>N.</given-names></name>
<name><surname>Falagas</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Toxoplasmosis snapshots: Global status of <italic toggle="yes">Toxoplasma gondii</italic> seroprevalence and implications for pregnancy and congenital toxoplasmosis</article-title><source>Int. J. Parasitol.</source><year>2009</year><volume>39</volume><fpage>1385</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2009.04.003</pub-id><pub-id pub-id-type="pmid">19433092</pub-id>
</element-citation></ref><ref id="B5-toxins-17-00095"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>At&#x00131;lla</surname><given-names>A.</given-names></name>
<name><surname>Aydin</surname><given-names>S.</given-names></name>
<name><surname>Dem&#x00131;rd&#x000f6;ven</surname><given-names>A.N.</given-names></name>
<name><surname>Kili&#x000e7;</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Severe Toxoplasmic Hepatitis in an Immunocompetent Patient</article-title><source>Jpn. J. Infect. Dis.</source><year>2015</year><volume>68</volume><fpage>407</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.7883/yoken.JJID.2014.422</pub-id><pub-id pub-id-type="pmid">25766609</pub-id>
</element-citation></ref><ref id="B6-toxins-17-00095"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ander</surname><given-names>S.E.</given-names></name>
<name><surname>Rudzki</surname><given-names>E.N.</given-names></name>
<name><surname>Arora</surname><given-names>N.</given-names></name>
<name><surname>Sadovsky</surname><given-names>Y.</given-names></name>
<name><surname>Coyne</surname><given-names>C.B.</given-names></name>
<name><surname>Boyle</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Human Placental Syncytiotrophoblasts Restrict <italic toggle="yes">Toxoplasma gondii</italic> Attachment and Replication and Respond to Infection by Producing Immunomodulatory Chemokines</article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>e01678-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.01678-17</pub-id><pub-id pub-id-type="pmid">29317509</pub-id>
</element-citation></ref><ref id="B7-toxins-17-00095"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Milne</surname><given-names>G.</given-names></name>
<name><surname>Webster</surname><given-names>J.P.</given-names></name>
<name><surname>Walker</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">Toxoplasma gondii:</italic> An Underestimated Threat?</article-title><source>Trends Parasitol.</source><year>2020</year><volume>36</volume><fpage>959</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2020.08.005</pub-id><pub-id pub-id-type="pmid">33012669</pub-id>
</element-citation></ref><ref id="B8-toxins-17-00095"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carellos</surname><given-names>E.V.</given-names></name>
<name><surname>Caiaffa</surname><given-names>W.T.</given-names></name>
<name><surname>Andrade</surname><given-names>G.M.</given-names></name>
<name><surname>Abreu</surname><given-names>M.N.</given-names></name>
<name><surname>Janu&#x000e1;rio</surname><given-names>J.N.</given-names></name>
<collab>UFMG Congenital Toxoplasmosis Brazilian Group (UFMG-CTBG)</collab>
</person-group><article-title>Congenital toxoplasmosis in the state of Minas Gerais, Brazil: A neglected infectious disease?</article-title><source>Epidemiol. Infect.</source><year>2014</year><volume>142</volume><fpage>644</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1017/S0950268813001507</pub-id><pub-id pub-id-type="pmid">23823156</pub-id>
</element-citation></ref><ref id="B9-toxins-17-00095"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Montoya</surname><given-names>J.G.</given-names></name>
<name><surname>Remington</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Management of <italic toggle="yes">Toxoplasma gondii</italic> infection during pregnancy</article-title><source>Clin. Infect. Dis.</source><year>2008</year><volume>47</volume><fpage>554</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1086/590149</pub-id><pub-id pub-id-type="pmid">18624630</pub-id>
</element-citation></ref><ref id="B10-toxins-17-00095"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peyron</surname><given-names>F.</given-names></name>
<name><surname>Mc Leod</surname><given-names>R.</given-names></name>
<name><surname>Ajzenberg</surname><given-names>D.</given-names></name>
<name><surname>Contopoulos-Ioannidis</surname><given-names>D.</given-names></name>
<name><surname>Kieffer</surname><given-names>F.</given-names></name>
<name><surname>Mandelbrot</surname><given-names>L.</given-names></name>
<name><surname>Sibley</surname><given-names>L.D.</given-names></name>
<name><surname>Pelloux</surname><given-names>H.</given-names></name>
<name><surname>Villena</surname><given-names>I.</given-names></name>
<name><surname>Wallon</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005222</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005222</pub-id><pub-id pub-id-type="pmid">28207736</pub-id>
</element-citation></ref><ref id="B11-toxins-17-00095"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al Nasr</surname><given-names>I.</given-names></name>
<name><surname>Ahmed</surname><given-names>F.</given-names></name>
<name><surname>Pullishery</surname><given-names>F.</given-names></name>
<name><surname>El-Ashram</surname><given-names>S.</given-names></name>
<name><surname>Ramaiah</surname><given-names>V.V.</given-names></name>
</person-group><article-title>Toxoplasmosis and anti-<italic toggle="yes">Toxoplasma</italic> effects of medicinal plant extracts-A mini-review</article-title><source>Asian Pac. J. Trop. Med.</source><year>2016</year><volume>9</volume><fpage>730</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1016/j.apjtm.2016.06.012</pub-id><pub-id pub-id-type="pmid">27569880</pub-id>
</element-citation></ref><ref id="B12-toxins-17-00095"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Montazeri</surname><given-names>M.</given-names></name>
<name><surname>Sharif</surname><given-names>M.</given-names></name>
<name><surname>Sarvi</surname><given-names>S.</given-names></name>
<name><surname>Mehrzadi</surname><given-names>S.</given-names></name>
<name><surname>Ahmadpour</surname><given-names>E.</given-names></name>
<name><surname>Daryani</surname><given-names>A.</given-names></name>
</person-group><article-title>A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006&#x02013;2016)</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.00025</pub-id><pub-id pub-id-type="pmid">28163699</pub-id>
</element-citation></ref><ref id="B13-toxins-17-00095"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peters</surname><given-names>P.J.</given-names></name>
<name><surname>Thigpen</surname><given-names>M.C.</given-names></name>
<name><surname>Parise</surname><given-names>M.E.</given-names></name>
<name><surname>Newman</surname><given-names>R.D.</given-names></name>
</person-group><article-title>Safety and toxicity of sulfadoxine/pyrimethamine: Implications for malaria prevention in pregnancy using intermittent preventive treatment</article-title><source>Drug Saf.</source><year>2007</year><volume>30</volume><fpage>481</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.2165/00002018-200730060-00003</pub-id><pub-id pub-id-type="pmid">17536875</pub-id>
</element-citation></ref><ref id="B14-toxins-17-00095"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kadri</surname><given-names>D.</given-names></name>
<name><surname>Crater</surname><given-names>A.K.</given-names></name>
<name><surname>Lee</surname><given-names>H.</given-names></name>
<name><surname>Solomon</surname><given-names>V.R.</given-names></name>
<name><surname>Ananvoranich</surname><given-names>S.</given-names></name>
</person-group><article-title>The potential of quinoline derivatives for the treatment of <italic toggle="yes">Toxoplasma gondii</italic> infection</article-title><source>Exp. Parasitol.</source><year>2014</year><volume>145</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2014.08.008</pub-id><pub-id pub-id-type="pmid">25128801</pub-id>
</element-citation></ref><ref id="B15-toxins-17-00095"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meneceur</surname><given-names>P.</given-names></name>
<name><surname>Bouldouyre</surname><given-names>M.A.</given-names></name>
<name><surname>Aubert</surname><given-names>D.</given-names></name>
<name><surname>Villena</surname><given-names>I.</given-names></name>
<name><surname>Menotti</surname><given-names>J.</given-names></name>
<name><surname>Sauvage</surname><given-names>V.</given-names></name>
<name><surname>Garin</surname><given-names>J.F.</given-names></name>
<name><surname>Derouin</surname><given-names>F.</given-names></name>
</person-group><article-title>In vitro susceptibility of various genotypic strains of <italic toggle="yes">Toxoplasma gondii</italic> to pyrimethamine, sulfadiazine, and atovaquone</article-title><source>Antimicrob. Agents Chemother.</source><year>2008</year><volume>52</volume><fpage>1269</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1128/AAC.01203-07</pub-id><pub-id pub-id-type="pmid">18212105</pub-id>
</element-citation></ref><ref id="B16-toxins-17-00095"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>L.A.</given-names></name>
<name><surname>Reis-Cunha</surname><given-names>J.L.</given-names></name>
<name><surname>Bartholomeu</surname><given-names>D.C.</given-names></name>
<name><surname>V&#x000ed;tor</surname><given-names>R.W.</given-names></name>
</person-group><article-title>Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive <italic toggle="yes">Toxoplasma gondii</italic> Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0170689</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0170689</pub-id><pub-id pub-id-type="pmid">28118394</pub-id>
</element-citation></ref><ref id="B17-toxins-17-00095"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Montazeri</surname><given-names>M.</given-names></name>
<name><surname>Mehrzadi</surname><given-names>S.</given-names></name>
<name><surname>Sharif</surname><given-names>M.</given-names></name>
<name><surname>Sarvi</surname><given-names>S.</given-names></name>
<name><surname>Tanzifi</surname><given-names>A.</given-names></name>
<name><surname>Aghayan</surname><given-names>S.A.</given-names></name>
<name><surname>Daryani</surname><given-names>A.</given-names></name>
</person-group><article-title>Drug Resistance in <italic toggle="yes">Toxoplasma gondii</italic></article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><elocation-id>2587</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.02587</pub-id><pub-id pub-id-type="pmid">30420849</pub-id>
</element-citation></ref><ref id="B18-toxins-17-00095"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Atanasov</surname><given-names>A.G.</given-names></name>
<name><surname>Zotchev</surname><given-names>S.B.</given-names></name>
<name><surname>Dirsch</surname><given-names>V.M.</given-names></name>
<collab>International Natural Product Sciences Taskforce</collab>
<name><surname>Supuran</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Natural products in drug discovery: Advances and opportunities</article-title><source>Nat. Rev. Drug Discov.</source><year>2021</year><volume>20</volume><fpage>200</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/s41573-020-00114-z</pub-id><pub-id pub-id-type="pmid">33510482</pub-id>
</element-citation></ref><ref id="B19-toxins-17-00095"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rodrigues</surname><given-names>V.M.</given-names></name>
<name><surname>Lopes</surname><given-names>D.S.</given-names></name>
<name><surname>Castanheira</surname><given-names>L.E.</given-names></name>
<name><surname>Gimenes</surname><given-names>S.N.</given-names></name>
<name><surname>Naves de Souza</surname><given-names>D.L.</given-names></name>
<name><surname>Ache</surname><given-names>D.C.</given-names></name>
<name><surname>Borges</surname><given-names>I.P.</given-names></name>
<name><surname>Yoneyama</surname><given-names>K.A.</given-names></name>
<name><surname>Rodrigues</surname><given-names>R.S.</given-names></name>
</person-group><article-title><italic toggle="yes">Bothrops pauloensis</italic> snake venom toxins: The search for new therapeutic models</article-title><source>Curr. Top. Med. Chem.</source><year>2015</year><volume>15</volume><fpage>670</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.2174/1568026615666150217120347</pub-id><pub-id pub-id-type="pmid">25686731</pub-id>
</element-citation></ref><ref id="B20-toxins-17-00095"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guti&#x000e9;rrez</surname><given-names>J.M.</given-names></name>
<name><surname>Calvete</surname><given-names>J.J.</given-names></name>
<name><surname>Habib</surname><given-names>A.G.</given-names></name>
<name><surname>Harrison</surname><given-names>R.A.</given-names></name>
<name><surname>Williams</surname><given-names>D.J.</given-names></name>
<name><surname>Warrell</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Snakebite envenoming</article-title><source>Nat. Rev. Dis. Primers</source><year>2017</year><volume>3</volume><fpage>17063</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2017.63</pub-id><pub-id pub-id-type="pmid">28905944</pub-id>
</element-citation></ref><ref id="B21-toxins-17-00095"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alves de Melo Fernandes</surname><given-names>T.</given-names></name>
<name><surname>Rafaella Costa</surname><given-names>T.</given-names></name>
<name><surname>de Paula Menezes</surname><given-names>R.</given-names></name>
<name><surname>Arantes de Souza</surname><given-names>M.</given-names></name>
<name><surname>Gomes Martins</surname><given-names>C.H.</given-names></name>
<name><surname>Junior</surname><given-names>N.N.</given-names></name>
<name><surname>Gobbi Amorim</surname><given-names>F.</given-names></name>
<name><surname>Quinton</surname><given-names>L.</given-names></name>
<name><surname>Polloni</surname><given-names>L.</given-names></name>
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Bothrops</italic> snake venom L-amino acid oxidases impair biofilm formation of clinically relevant bacteria</article-title><source>Toxicon</source><year>2024</year><volume>238</volume><fpage>107569</fpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2023.107569</pub-id><pub-id pub-id-type="pmid">38122835</pub-id>
</element-citation></ref><ref id="B22-toxins-17-00095"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Vasconcelos Azevedo</surname><given-names>F.V.P.</given-names></name>
<name><surname>Z&#x000f3;ia</surname><given-names>M.A.P.</given-names></name>
<name><surname>Lopes</surname><given-names>D.S.</given-names></name>
<name><surname>Gimenes</surname><given-names>S.N.</given-names></name>
<name><surname>Vecchi</surname><given-names>L.</given-names></name>
<name><surname>Alves</surname><given-names>P.T.</given-names></name>
<name><surname>Rodrigues</surname><given-names>R.S.</given-names></name>
<name><surname>Silva</surname><given-names>A.C.A.</given-names></name>
<name><surname>Yoneyama</surname><given-names>K.A.G.</given-names></name>
<name><surname>Goulart</surname><given-names>L.R.</given-names></name>
<etal/>
</person-group><article-title>Antitumor and antimetastatic effects of PLA2-BthTX-II from <italic toggle="yes">Bothrops jararacussu</italic> venom on human breast cancer cells</article-title><source>Int. J. Biol. Macromol.</source><year>2019</year><volume>135</volume><fpage>261</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.05.164</pub-id><pub-id pub-id-type="pmid">31128190</pub-id>
</element-citation></ref><ref id="B23-toxins-17-00095"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<name><surname>Borges</surname><given-names>B.C.</given-names></name>
<name><surname>Oliveira</surname><given-names>V.Q.</given-names></name>
<name><surname>Carregosa</surname><given-names>L.S.</given-names></name>
<name><surname>Bastos</surname><given-names>L.A.</given-names></name>
<name><surname>Santos</surname><given-names>I.A.</given-names></name>
<name><surname>Jardim</surname><given-names>A.C.G.</given-names></name>
<name><surname>Melo</surname><given-names>F.F.</given-names></name>
<name><surname>Freitas</surname><given-names>L.M.</given-names></name>
<name><surname>Rodrigues</surname><given-names>V.M.</given-names></name>
<etal/>
</person-group><article-title>Insights into the antiviral activity of phospholipases A2 (PLA2s) from snake venoms</article-title><source>Int. J. Biol. Macromol.</source><year>2020</year><volume>164</volume><fpage>616</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.07.178</pub-id><pub-id pub-id-type="pmid">32698062</pub-id>
</element-citation></ref><ref id="B24-toxins-17-00095"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cassani</surname><given-names>N.M.</given-names></name>
<name><surname>Santos</surname><given-names>I.A.</given-names></name>
<name><surname>Grosche</surname><given-names>V.R.</given-names></name>
<name><surname>Ferreira</surname><given-names>G.M.</given-names></name>
<name><surname>Guevara-Vega</surname><given-names>M.</given-names></name>
<name><surname>Rosa</surname><given-names>R.B.</given-names></name>
<name><surname>Pena</surname><given-names>L.J.</given-names></name>
<name><surname>Nicolau-Junior</surname><given-names>N.</given-names></name>
<name><surname>Cintra</surname><given-names>A.C.O.</given-names></name>
<name><surname>Mineo</surname><given-names>T.P.</given-names></name>
<etal/>
</person-group><article-title>Roles of <italic toggle="yes">Bothrops jararacussu</italic> toxins I and II: Antiviral findings against Zika virus</article-title><source>Int. J. Biol. Macromol.</source><year>2023</year><volume>227</volume><fpage>630</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.12.102</pub-id><pub-id pub-id-type="pmid">36529220</pub-id>
</element-citation></ref><ref id="B25-toxins-17-00095"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<name><surname>da Silva</surname><given-names>M.S.</given-names></name>
<name><surname>Gomes</surname><given-names>A.A.S.</given-names></name>
<name><surname>Moretti</surname><given-names>N.S.</given-names></name>
<name><surname>Lopes</surname><given-names>D.S.</given-names></name>
<name><surname>Ferro</surname><given-names>E.A.V.</given-names></name>
<name><surname>Rodrigues</surname><given-names>V.M.</given-names></name>
</person-group><article-title>Panacea within a Pandora&#x02019;s box: The antiparasitic effects of phospholipases A2 (PLA2s) from snake venoms</article-title><source>Trends Parasitol.</source><year>2022</year><volume>38</volume><fpage>80</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2021.07.004</pub-id><pub-id pub-id-type="pmid">34364805</pub-id>
</element-citation></ref><ref id="B26-toxins-17-00095"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Melo Fernandes</surname><given-names>T.A.</given-names></name>
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<name><surname>Costa</surname><given-names>T.R.</given-names></name>
<name><surname>Rosini</surname><given-names>A.M.</given-names></name>
<name><surname>de Souza</surname><given-names>G.</given-names></name>
<name><surname>Polloni</surname><given-names>L.</given-names></name>
<name><surname>Barbosa</surname><given-names>B.F.</given-names></name>
<name><surname>Silva</surname><given-names>M.J.B.</given-names></name>
<name><surname>Ferro</surname><given-names>E.A.V.</given-names></name>
<name><surname>&#x000c1;vila</surname><given-names>V.M.R.</given-names></name>
</person-group><article-title>BjussuLAAO-II, an L-amino acid oxidase from <italic toggle="yes">Bothrops jararacussu</italic> snake venom, impairs <italic toggle="yes">Toxoplasma gondii</italic> infection in human trophoblast cells and villous explants from the third trimester of pregnancy</article-title><source>Microbes Infect.</source><year>2023</year><volume>25</volume><fpage>105123</fpage><pub-id pub-id-type="doi">10.1016/j.micinf.2023.105123</pub-id><pub-id pub-id-type="pmid">36870599</pub-id>
</element-citation></ref><ref id="B27-toxins-17-00095"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fox</surname><given-names>J.W.</given-names></name>
<name><surname>Serrano</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity</article-title><source>FEBS J.</source><year>2008</year><volume>275</volume><fpage>3016</fpage><lpage>3030</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2008.06466.x</pub-id><pub-id pub-id-type="pmid">18479462</pub-id>
</element-citation></ref><ref id="B28-toxins-17-00095"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naves de Souza</surname><given-names>D.L.</given-names></name>
<name><surname>Gomes</surname><given-names>M.S.</given-names></name>
<name><surname>Ferreira</surname><given-names>F.B.</given-names></name>
<name><surname>Rodrigues</surname><given-names>R.S.</given-names></name>
<name><surname>Ach&#x000ea;</surname><given-names>D.C.</given-names></name>
<name><surname>Richardson</surname><given-names>M.</given-names></name>
<name><surname>Borges</surname><given-names>M.H.</given-names></name>
<name><surname>Rodrigues</surname><given-names>V.M.</given-names></name>
</person-group><article-title>Biochemical and enzymatic characterization of BpMP-I, a fibrinogenolytic metalloproteinase isolated from <italic toggle="yes">Bothropoides pauloensis</italic> snake venom</article-title><source>Comp. Biochem. Physiol. B Biochem. Mol. Biol.</source><year>2012</year><volume>161</volume><fpage>102</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.cbpb.2011.10.002</pub-id><pub-id pub-id-type="pmid">22008900</pub-id>
</element-citation></ref><ref id="B29-toxins-17-00095"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paine</surname><given-names>M.J.</given-names></name>
<name><surname>Desmond</surname><given-names>H.P.</given-names></name>
<name><surname>Theakston</surname><given-names>R.D.</given-names></name>
<name><surname>Crampton</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from <italic toggle="yes">Bothrops jararaca</italic> venom. Insights into the disintegrin gene family</article-title><source>J. Biol. Chem.</source><year>1992</year><volume>267</volume><fpage>22869</fpage><lpage>22876</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)50027-2</pub-id><pub-id pub-id-type="pmid">1385408</pub-id>
</element-citation></ref><ref id="B30-toxins-17-00095"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Usami</surname><given-names>Y.</given-names></name>
<name><surname>Fujimura</surname><given-names>Y.</given-names></name>
<name><surname>Miura</surname><given-names>S.</given-names></name>
<name><surname>Shima</surname><given-names>H.</given-names></name>
<name><surname>Yoshida</surname><given-names>E.</given-names></name>
<name><surname>Yoshioka</surname><given-names>A.</given-names></name>
<name><surname>Hirano</surname><given-names>K.</given-names></name>
<name><surname>Suzuki</surname><given-names>M.</given-names></name>
<name><surname>Titani</surname><given-names>K.</given-names></name>
</person-group><article-title>A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from <italic toggle="yes">Bothrops jararaca</italic> venom inhibits collagen- and ADP-induced platelet aggregation</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1994</year><volume>201</volume><fpage>331</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1994.1706</pub-id><pub-id pub-id-type="pmid">8198592</pub-id>
</element-citation></ref><ref id="B31-toxins-17-00095"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferraz</surname><given-names>K.F.</given-names></name>
<name><surname>De Lucca Caetano</surname><given-names>L.H.</given-names></name>
<name><surname>Orefice</surname><given-names>D.P.</given-names></name>
<name><surname>Calabria</surname><given-names>P.A.L.</given-names></name>
<name><surname>Della-Casa</surname><given-names>M.S.</given-names></name>
<name><surname>Freitas-de-Sousa</surname><given-names>L.A.</given-names></name>
<name><surname>Beraldo-Neto</surname><given-names>E.</given-names></name>
<name><surname>Sanabani</surname><given-names>S.S.</given-names></name>
<name><surname>Magalh&#x000e3;es</surname><given-names>G.S.</given-names></name>
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
</person-group><article-title>Bicistronic Vector Expression of Recombinant Jararhagin-C and Its Effects on Endothelial Cells</article-title><source>Toxins</source><year>2024</year><volume>16</volume><elocation-id>524</elocation-id><pub-id pub-id-type="doi">10.3390/toxins16120524</pub-id><pub-id pub-id-type="pmid">39728782</pub-id>
</element-citation></ref><ref id="B32-toxins-17-00095"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bastos</surname><given-names>L.M.</given-names></name>
<name><surname>J&#x000fa;nior</surname><given-names>R.J.</given-names></name>
<name><surname>Silva</surname><given-names>D.A.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
<name><surname>Vieira</surname><given-names>C.U.</given-names></name>
<name><surname>Teixeira</surname><given-names>D.N.</given-names></name>
<name><surname>Homsi-Brandeburgo</surname><given-names>M.I.</given-names></name>
<name><surname>Rodrigues</surname><given-names>V.M.</given-names></name>
<name><surname>Hamaguchi</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Toxoplasma gondii</italic>: Effects of neuwiedase, a metalloproteinase from <italic toggle="yes">Bothrops neuwiedi</italic> snake venom, on the invasion and replication of human fibroblasts in vitro</article-title><source>Exp. Parasitol.</source><year>2008</year><volume>120</volume><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2008.09.008</pub-id><pub-id pub-id-type="pmid">18823981</pub-id>
</element-citation></ref><ref id="B33-toxins-17-00095"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ehsan</surname><given-names>A.</given-names></name>
<name><surname>Elmira</surname><given-names>Z.</given-names></name>
<name><surname>Mahmoud</surname><given-names>M.</given-names></name>
<name><surname>Andel</surname><given-names>S.</given-names></name>
<name><surname>Abbas</surname><given-names>S.</given-names></name>
<name><surname>Samadi</surname><given-names>K.H.</given-names></name>
<name><surname>Saba</surname><given-names>R.</given-names></name>
<name><surname>Paria</surname><given-names>A.</given-names></name>
<name><surname>Yagoob</surname><given-names>A.</given-names></name>
<name><surname>Reza</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Diagnosis of <italic toggle="yes">Toxoplasma gondii</italic> infection in pregnant women using automated chemiluminescence and quantitative real time PCR</article-title><source>Asian Pac. J. Trop. Med.</source><year>2019</year><volume>12</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.4103/1995-7645.250341</pub-id></element-citation></ref><ref id="B34-toxins-17-00095"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oliveira</surname><given-names>A.L.</given-names></name>
<name><surname>Viegas</surname><given-names>M.F.</given-names></name>
<name><surname>da Silva</surname><given-names>S.L.</given-names></name>
<name><surname>Soares</surname><given-names>A.M.</given-names></name>
<name><surname>Ramos</surname><given-names>M.J.</given-names></name>
<name><surname>Fernandes</surname><given-names>P.A.</given-names></name>
</person-group><article-title>The chemistry of snake venom and its medicinal potential</article-title><source>Nat. Rev. Chem.</source><year>2022</year><volume>6</volume><fpage>451</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/s41570-022-00393-7</pub-id><pub-id pub-id-type="pmid">37117308</pub-id>
</element-citation></ref><ref id="B35-toxins-17-00095"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>J.R.</given-names></name>
<name><surname>Gomes</surname><given-names>A.</given-names></name>
<name><surname>Mendes</surname><given-names>B.</given-names></name>
<name><surname>Aguiar</surname><given-names>L.</given-names></name>
<name><surname>Ferreira</surname><given-names>M.</given-names></name>
<name><surname>Brioschi</surname><given-names>M.B.C.</given-names></name>
<name><surname>Duarte</surname><given-names>D.</given-names></name>
<name><surname>Nogueira</surname><given-names>F.</given-names></name>
<name><surname>Cortes</surname><given-names>S.</given-names></name>
<name><surname>Salazar-Valenzuela</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Unlocking the potential of snake venom-based molecules against the malaria, Chagas disease, and leishmaniasis triad</article-title><source>Int. J. Biol. Macromol.</source><year>2023</year><volume>242</volume><issue-part>Pt 2</issue-part><elocation-id>124745</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.124745</pub-id><pub-id pub-id-type="pmid">37150376</pub-id>
</element-citation></ref><ref id="B36-toxins-17-00095"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdullahi</surname><given-names>Z.U.</given-names></name>
<name><surname>Musa</surname><given-names>S.S.</given-names></name>
<name><surname>He</surname><given-names>D.</given-names></name>
<name><surname>Bello</surname><given-names>U.M.</given-names></name>
</person-group><article-title>Antiprotozoal Effect of Snake Venoms and Their Fractions: A Systematic Review</article-title><source>Pathogens</source><year>2021</year><volume>10</volume><elocation-id>1632</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens10121632</pub-id><pub-id pub-id-type="pmid">34959587</pub-id>
</element-citation></ref><ref id="B37-toxins-17-00095"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kayano</surname><given-names>A.M.</given-names></name>
<name><surname>Sim&#x000f5;es-Silva</surname><given-names>R.</given-names></name>
<name><surname>Medeiros</surname><given-names>P.S.</given-names></name>
<name><surname>Maltarollo</surname><given-names>V.G.</given-names></name>
<name><surname>Honorio</surname><given-names>K.M.</given-names></name>
<name><surname>Oliveira</surname><given-names>E.</given-names></name>
<name><surname>Albericio</surname><given-names>F.</given-names></name>
<name><surname>da Silva</surname><given-names>S.L.</given-names></name>
<name><surname>Aguiar</surname><given-names>A.C.</given-names></name>
<name><surname>Krettli</surname><given-names>A.U.</given-names></name>
<etal/>
</person-group><article-title>BbMP-1, a new metalloproteinase isolated from <italic toggle="yes">Bothrops brazili</italic> snake venom with in vitro antiplasmodial properties</article-title><source>Toxicon</source><year>2015</year><volume>106</volume><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2015.09.005</pub-id><pub-id pub-id-type="pmid">26363289</pub-id>
</element-citation></ref><ref id="B38-toxins-17-00095"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martins</surname><given-names>G.G.</given-names></name>
<name><surname>de Jesus Holanda</surname><given-names>R.</given-names></name>
<name><surname>Alfonso</surname><given-names>J.</given-names></name>
<name><surname>G&#x000f3;mez Garay</surname><given-names>A.F.</given-names></name>
<name><surname>Dos Santos</surname><given-names>A.P.A.</given-names></name>
<name><surname>de Lima</surname><given-names>A.M.</given-names></name>
<name><surname>Francisco</surname><given-names>A.F.</given-names></name>
<name><surname>Garcia Teles</surname><given-names>C.B.</given-names></name>
<name><surname>Zanchi</surname><given-names>F.B.</given-names></name>
<name><surname>Soares</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Identification of a peptide derived from a <italic toggle="yes">Bothrops moojeni</italic> metalloprotease with in vitro inhibitory action on the <italic toggle="yes">Plasmodium falciparum</italic> purine nucleoside phosphorylase enzyme (PfPNP)</article-title><source>Biochimie</source><year>2019</year><volume>162</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2019.04.009</pub-id><pub-id pub-id-type="pmid">30978375</pub-id>
</element-citation></ref><ref id="B39-toxins-17-00095"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barbosa</surname><given-names>B.F.</given-names></name>
<name><surname>Lopes-Maria</surname><given-names>J.B.</given-names></name>
<name><surname>Gomes</surname><given-names>A.O.</given-names></name>
<name><surname>Angeloni</surname><given-names>M.B.</given-names></name>
<name><surname>Castro</surname><given-names>A.S.</given-names></name>
<name><surname>Franco</surname><given-names>P.S.</given-names></name>
<name><surname>Fermino</surname><given-names>M.L.</given-names></name>
<name><surname>Roque-Barreira</surname><given-names>M.C.</given-names></name>
<name><surname>Ietta</surname><given-names>F.</given-names></name>
<name><surname>Martins-Filho</surname><given-names>O.A.</given-names></name>
<etal/>
</person-group><article-title>IL10, TGF beta1, and IFN gamma modulate intracellular signaling pathways and cytokine production to control <italic toggle="yes">Toxoplasma gondii</italic> infection in BeWo trophoblast cells</article-title><source>Biol. Reprod.</source><year>2015</year><volume>92</volume><elocation-id>82</elocation-id><pub-id pub-id-type="doi">10.1095/biolreprod.114.124115</pub-id><pub-id pub-id-type="pmid">25673564</pub-id>
</element-citation></ref><ref id="B40-toxins-17-00095"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barbosa</surname><given-names>B.F.</given-names></name>
<name><surname>Paulesu</surname><given-names>L.</given-names></name>
<name><surname>Ietta</surname><given-names>F.</given-names></name>
<name><surname>Bechi</surname><given-names>N.</given-names></name>
<name><surname>Romagnoli</surname><given-names>R.</given-names></name>
<name><surname>Gomes</surname><given-names>A.O.</given-names></name>
<name><surname>Favoreto-Junior</surname><given-names>S.</given-names></name>
<name><surname>Silva</surname><given-names>D.A.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
<name><surname>Mineo</surname><given-names>T.W.</given-names></name>
<etal/>
</person-group><article-title>Susceptibility to <italic toggle="yes">Toxoplasma gondii</italic> proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1/2 phosphorylation and prostaglandin E2 production</article-title><source>Placenta</source><year>2014</year><volume>35</volume><fpage>152</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2013.12.013</pub-id><pub-id pub-id-type="pmid">24433846</pub-id>
</element-citation></ref><ref id="B41-toxins-17-00095"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castro-Filice</surname><given-names>L.S.</given-names></name>
<name><surname>Barbosa</surname><given-names>B.F.</given-names></name>
<name><surname>Angeloni</surname><given-names>M.B.</given-names></name>
<name><surname>Silva</surname><given-names>N.M.</given-names></name>
<name><surname>Gomes</surname><given-names>A.O.</given-names></name>
<name><surname>Alves</surname><given-names>C.M.</given-names></name>
<name><surname>Silva</surname><given-names>D.A.</given-names></name>
<name><surname>Martins-Filho</surname><given-names>O.A.</given-names></name>
<name><surname>Santos</surname><given-names>M.C.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
<etal/>
</person-group><article-title>Azithromycin is able to control <italic toggle="yes">Toxoplasma gondii</italic> infection in human villous explants</article-title><source>J. Transl. Med.</source><year>2014</year><volume>12</volume><fpage>132</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-12-132</pub-id><pub-id pub-id-type="pmid">24885122</pub-id>
</element-citation></ref><ref id="B42-toxins-17-00095"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Souza</surname><given-names>G.</given-names></name>
<name><surname>Silva</surname><given-names>R.J.</given-names></name>
<name><surname>Mili&#x000e1;n</surname><given-names>I.C.B.</given-names></name>
<name><surname>Rosini</surname><given-names>A.M.</given-names></name>
<name><surname>de Ara&#x000fa;jo</surname><given-names>T.E.</given-names></name>
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<name><surname>Oliveira</surname><given-names>M.C.</given-names></name>
<name><surname>Franco</surname><given-names>P.S.</given-names></name>
<name><surname>da Silva</surname><given-names>C.V.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
<etal/>
</person-group><article-title>Cyclooxygenase (COX)-2 modulates <italic toggle="yes">Toxoplasma gondii</italic> infection, immune response and lipid droplets formation in human trophoblast cells and villous explants</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><elocation-id>12709</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-92120-3</pub-id><pub-id pub-id-type="pmid">34135407</pub-id>
</element-citation></ref><ref id="B43-toxins-17-00095"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
<name><surname>Laing</surname><given-names>G.D.</given-names></name>
<name><surname>Theakston</surname><given-names>R.D.</given-names></name>
<name><surname>Mota</surname><given-names>I.</given-names></name>
<name><surname>Taylor</surname><given-names>M.J.</given-names></name>
<name><surname>Moura-da-Silva</surname><given-names>A.M.</given-names></name>
</person-group><article-title>The effect of jararhagin, a metalloproteinase from <italic toggle="yes">Bothrops jararaca</italic> venom, on pro-inflammatory cytokines released by murine peritoneal adherent cells</article-title><source>Toxicon</source><year>2001</year><volume>39</volume><fpage>1567</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(01)00131-3</pub-id><pub-id pub-id-type="pmid">11478964</pub-id>
</element-citation></ref><ref id="B44-toxins-17-00095"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>M.C.</given-names></name>
<name><surname>Lopes Silva</surname><given-names>T.</given-names></name>
<name><surname>Silva</surname><given-names>M.V.</given-names></name>
<name><surname>Mota</surname><given-names>C.M.</given-names></name>
<name><surname>Santiago</surname><given-names>F.M.</given-names></name>
<name><surname>Fonseca</surname><given-names>K.C.</given-names></name>
<name><surname>Oliveira</surname><given-names>F.</given-names></name>
<name><surname>Mineo</surname><given-names>T.W.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Interaction between TNF and BmooMP-Alpha-I, a Zinc Metalloprotease Derived from <italic toggle="yes">Bothrops moojeni</italic> Snake Venom, Promotes Direct Proteolysis of This Cytokine: Molecular Modeling and Docking at a Glance</article-title><source>Toxins</source><year>2016</year><volume>8</volume><elocation-id>223</elocation-id><pub-id pub-id-type="doi">10.3390/toxins8070223</pub-id><pub-id pub-id-type="pmid">27447669</pub-id>
</element-citation></ref><ref id="B45-toxins-17-00095"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayashi</surname><given-names>F.</given-names></name>
<name><surname>Means</surname><given-names>T.K.</given-names></name>
<name><surname>Luster</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Toll-like receptors stimulate human neutrophil function</article-title><source>Blood</source><year>2003</year><volume>102</volume><fpage>2660</fpage><lpage>2669</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-04-1078</pub-id><pub-id pub-id-type="pmid">12829592</pub-id>
</element-citation></ref><ref id="B46-toxins-17-00095"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flores</surname><given-names>M.</given-names></name>
<name><surname>Saavedra</surname><given-names>R.</given-names></name>
<name><surname>Bautista</surname><given-names>R.</given-names></name>
<name><surname>Viedma</surname><given-names>R.</given-names></name>
<name><surname>Tenorio</surname><given-names>E.P.</given-names></name>
<name><surname>Leng</surname><given-names>L.</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>Y.</given-names></name>
<name><surname>Ju&#x000e1;rez</surname><given-names>I.</given-names></name>
<name><surname>Satoskar</surname><given-names>A.A.</given-names></name>
<name><surname>Shenoy</surname><given-names>A.S.</given-names></name>
<etal/>
</person-group><article-title>Macrophage migration inhibitory factor (MIF) is critical for the host resistance against <italic toggle="yes">Toxoplasma gondii</italic></article-title><source>FASEB J.</source><year>2008</year><volume>22</volume><fpage>3661</fpage><lpage>3671</lpage><pub-id pub-id-type="doi">10.1096/fj.08-111666</pub-id><pub-id pub-id-type="pmid">18606868</pub-id>
</element-citation></ref><ref id="B47-toxins-17-00095"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Oliveira Gomes</surname><given-names>A.</given-names></name>
<name><surname>de Oliveira Silva</surname><given-names>D.A.</given-names></name>
<name><surname>Silva</surname><given-names>N.M.</given-names></name>
<name><surname>de Freitas Barbosa</surname><given-names>B.</given-names></name>
<name><surname>Franco</surname><given-names>P.S.</given-names></name>
<name><surname>Angeloni</surname><given-names>M.B.</given-names></name>
<name><surname>Fermino</surname><given-names>M.L.</given-names></name>
<name><surname>Roque-Barreira</surname><given-names>M.C.</given-names></name>
<name><surname>Bechi</surname><given-names>N.</given-names></name>
<name><surname>Paulesu</surname><given-names>L.R.</given-names></name>
<etal/>
</person-group><article-title>Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with <italic toggle="yes">Toxoplasma gondii</italic> depends on gestational age</article-title><source>Am. J. Pathol.</source><year>2011</year><volume>178</volume><fpage>2792</fpage><lpage>2801</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.02.005</pub-id><pub-id pub-id-type="pmid">21641401</pub-id>
</element-citation></ref><ref id="B48-toxins-17-00095"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>P.T.M.</given-names></name>
<name><surname>Oliveira-Scussel</surname><given-names>A.C.M.</given-names></name>
<name><surname>Sousa</surname><given-names>R.A.P.</given-names></name>
<name><surname>Gomes</surname><given-names>B.Q.</given-names></name>
<name><surname>F&#x000e9;lix</surname><given-names>J.E.</given-names></name>
<name><surname>Silva</surname><given-names>R.J.</given-names></name>
<name><surname>Millian</surname><given-names>I.B.</given-names></name>
<name><surname>Assun&#x000e7;&#x000e3;o</surname><given-names>T.S.F.</given-names></name>
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<name><surname>Gomes</surname><given-names>M.L.M.</given-names></name>
<etal/>
</person-group><article-title>Macrophage Migration Inhibitory Factor contributes to drive phenotypic and functional macrophages activation in response to <italic toggle="yes">Toxoplasma gondii</italic> infection</article-title><source>Immunobiology</source><year>2023</year><volume>228</volume><elocation-id>152357</elocation-id><pub-id pub-id-type="doi">10.1016/j.imbio.2023.152357</pub-id><pub-id pub-id-type="pmid">36857907</pub-id>
</element-citation></ref><ref id="B49-toxins-17-00095"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>B.A.</given-names></name>
<name><surname>Deconte</surname><given-names>S.R.</given-names></name>
<name><surname>de Moura</surname><given-names>F.B.R.</given-names></name>
<name><surname>Tomiosso</surname><given-names>T.C.</given-names></name>
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
<name><surname>Andrade</surname><given-names>S.P.</given-names></name>
<name><surname>Ara&#x000fa;jo</surname><given-names>F.A.</given-names></name>
</person-group><article-title>Inflammation, angiogenesis and fibrogenesis are differentially modulated by distinct domains of the snake venom metalloproteinase jararhagin</article-title><source>Int. J. Biol. Macromol.</source><year>2018</year><volume>119</volume><fpage>1179</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.08.051</pub-id><pub-id pub-id-type="pmid">30102981</pub-id>
</element-citation></ref><ref id="B50-toxins-17-00095"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moura-da-Silva</surname><given-names>A.M.</given-names></name>
<name><surname>Baldo</surname><given-names>C.</given-names></name>
</person-group><article-title>Jararhagin, a hemorrhagic snake venom metalloproteinase from <italic toggle="yes">Bothrops jararaca</italic></article-title><source>Toxicon</source><year>2012</year><volume>60</volume><fpage>280</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2012.03.026</pub-id><pub-id pub-id-type="pmid">22534074</pub-id>
</element-citation></ref><ref id="B51-toxins-17-00095"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
<name><surname>Lopes-Ferreira</surname><given-names>M.</given-names></name>
<name><surname>Della-Casa</surname><given-names>M.S.</given-names></name>
<name><surname>Farsky</surname><given-names>S.H.</given-names></name>
<name><surname>Moura-da-Silva</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Importance of jararhagin disintegrin-like and cysteine-rich domains in the early events of local inflammatory response</article-title><source>Toxicon</source><year>2006</year><volume>47</volume><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2006.02.001</pub-id><pub-id pub-id-type="pmid">16564063</pub-id>
</element-citation></ref><ref id="B52-toxins-17-00095"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moura-da-Silva</surname><given-names>A.M.</given-names></name>
<name><surname>L&#x000ed;nica</surname><given-names>A.</given-names></name>
<name><surname>Della-Casa</surname><given-names>M.S.</given-names></name>
<name><surname>Kamiguti</surname><given-names>A.S.</given-names></name>
<name><surname>Ho</surname><given-names>P.L.</given-names></name>
<name><surname>Crampton</surname><given-names>J.M.</given-names></name>
<name><surname>Theakston</surname><given-names>R.D.</given-names></name>
</person-group><article-title>Jararhagin ECD-containing disintegrin domain: Expression in <italic toggle="yes">Escherichia coli</italic> and inhibition of the platelet-collagen interaction</article-title><source>Arch. Biochem. Biophys.</source><year>1999</year><volume>369</volume><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1006/abbi.1999.1372</pub-id><pub-id pub-id-type="pmid">10486149</pub-id>
</element-citation></ref><ref id="B53-toxins-17-00095"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>B.A.</given-names></name>
<name><surname>De Moura</surname><given-names>F.B.R.</given-names></name>
<name><surname>Tomiosso</surname><given-names>T.C.</given-names></name>
<name><surname>Corr&#x000ea;a</surname><given-names>N.C.R.</given-names></name>
<name><surname>Goulart</surname><given-names>L.R.</given-names></name>
<name><surname>Barcelos</surname><given-names>L.S.</given-names></name>
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
<name><surname>Ara&#x000fa;jo</surname><given-names>F.A.</given-names></name>
</person-group><article-title>Jararhagin-C, a disintegrin-like protein, improves wound healing in mice through stimulation of M2-like macrophage, angiogenesis and collagen deposition</article-title><source>Int. Immunopharmacol.</source><year>2021</year><volume>101 Pt B</volume><fpage>108224</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2021.108224</pub-id><pub-id pub-id-type="pmid">34655846</pub-id>
</element-citation></ref><ref id="B54-toxins-17-00095"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zychar</surname><given-names>B.C.</given-names></name>
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
<name><surname>Carvalho</surname><given-names>E.</given-names></name>
<name><surname>Baldo</surname><given-names>C.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>L.R.C.</given-names></name>
</person-group><article-title>Leukocyte recruitment induced by snake venom metalloproteinases: Role of the catalytic domain</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2020</year><volume>521</volume><fpage>402</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2019.10.144</pub-id><pub-id pub-id-type="pmid">31668920</pub-id>
</element-citation></ref><ref id="B55-toxins-17-00095"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zychar</surname><given-names>B.C.</given-names></name>
<name><surname>Clissa</surname><given-names>P.B.</given-names></name>
<name><surname>Carvalho</surname><given-names>E.</given-names></name>
<name><surname>Alves</surname><given-names>A.S.</given-names></name>
<name><surname>Baldo</surname><given-names>C.</given-names></name>
<name><surname>Faquim-Mauro</surname><given-names>E.L.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>L.R.C.</given-names></name>
</person-group><article-title>Modulation of Adhesion Molecules Expression by Different Metalloproteases Isolated from <italic toggle="yes">Bothrops</italic> Snakes</article-title><source>Toxins</source><year>2021</year><volume>13</volume><elocation-id>803</elocation-id><pub-id pub-id-type="doi">10.3390/toxins13110803</pub-id><pub-id pub-id-type="pmid">34822587</pub-id>
</element-citation></ref><ref id="B56-toxins-17-00095"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baldo</surname><given-names>C.</given-names></name>
<name><surname>Jamora</surname><given-names>C.</given-names></name>
<name><surname>Yamanouye</surname><given-names>N.</given-names></name>
<name><surname>Zorn</surname><given-names>T.M.</given-names></name>
<name><surname>Moura-da-Silva</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: Tissue distribution and in situ hydrolysis</article-title><source>PLoS Negl. Trop. Dis.</source><year>2010</year><volume>4</volume><elocation-id>e727</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0000727</pub-id><pub-id pub-id-type="pmid">20614020</pub-id>
</element-citation></ref><ref id="B57-toxins-17-00095"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Menezes</surname><given-names>M.C.</given-names></name>
<name><surname>de Oliveira</surname><given-names>A.K.</given-names></name>
<name><surname>Melo</surname><given-names>R.L.</given-names></name>
<name><surname>Lopes-Ferreira</surname><given-names>M.</given-names></name>
<name><surname>Rioli</surname><given-names>V.</given-names></name>
<name><surname>Balan</surname><given-names>A.</given-names></name>
<name><surname>Paes Leme</surname><given-names>A.F.</given-names></name>
<name><surname>Serrano</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Disintegrin-like/cysteine-rich domains of the reprolysin HF3: Site-directed mutagenesis reveals essential role of specific residues</article-title><source>Biochimie</source><year>2011</year><volume>93</volume><fpage>345</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2010.10.007</pub-id><pub-id pub-id-type="pmid">20955756</pub-id>
</element-citation></ref><ref id="B58-toxins-17-00095"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kamiguti</surname><given-names>A.S.</given-names></name>
<name><surname>Gallagher</surname><given-names>P.</given-names></name>
<name><surname>Marcinkiewicz</surname><given-names>C.</given-names></name>
<name><surname>Theakston</surname><given-names>R.D.</given-names></name>
<name><surname>Zuzel</surname><given-names>M.</given-names></name>
<name><surname>Fox</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Identification of sites in the cysteine-rich domain of the class P-III snake venom metalloproteinases responsible for inhibition of platelet function</article-title><source>FEBS Lett.</source><year>2003</year><volume>549</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(03)00799-3</pub-id><pub-id pub-id-type="pmid">12914938</pub-id>
</element-citation></ref><ref id="B59-toxins-17-00095"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takeda</surname><given-names>S.</given-names></name>
</person-group><article-title>Three-dimensional domain architecture of the ADAM family proteinases</article-title><source>Semin. Cell Dev. Biol.</source><year>2009</year><volume>20</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2008.07.009</pub-id><pub-id pub-id-type="pmid">18706512</pub-id>
</element-citation></ref><ref id="B60-toxins-17-00095"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takeda</surname><given-names>S.</given-names></name>
</person-group><article-title>ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview</article-title><source>Toxins</source><year>2016</year><volume>8</volume><elocation-id>155</elocation-id><pub-id pub-id-type="doi">10.3390/toxins8050155</pub-id><pub-id pub-id-type="pmid">27196928</pub-id>
</element-citation></ref><ref id="B61-toxins-17-00095"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Olaoba</surname><given-names>O.T.</given-names></name>
<name><surname>Karina Dos Santos</surname><given-names>P.</given-names></name>
<name><surname>Selistre-de-Araujo</surname><given-names>H.S.</given-names></name>
<name><surname>Ferreira de Souza</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Snake Venom Metalloproteinases (SVMPs): A structure-function update</article-title><source>Toxicon</source><year>2020</year><volume>7</volume><fpage>100052</fpage><pub-id pub-id-type="doi">10.1016/j.toxcx.2020.100052</pub-id><pub-id pub-id-type="pmid">32776002</pub-id>
</element-citation></ref><ref id="B62-toxins-17-00095"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jia</surname><given-names>L.G.</given-names></name>
<name><surname>Wang</surname><given-names>X.M.</given-names></name>
<name><surname>Shannon</surname><given-names>J.D.</given-names></name>
<name><surname>Bjarnason</surname><given-names>J.B.</given-names></name>
<name><surname>Fox</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Function of disintegrin-like/cysteine-rich domains of atrolysin, A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>13094</fpage><lpage>13102</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.20.13094</pub-id><pub-id pub-id-type="pmid">9148922</pub-id>
</element-citation></ref><ref id="B63-toxins-17-00095"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Furtado</surname><given-names>G.C.</given-names></name>
<name><surname>Slowik</surname><given-names>M.</given-names></name>
<name><surname>Kleinman</surname><given-names>H.K.</given-names></name>
<name><surname>Joiner</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Laminin enhances binding of <italic toggle="yes">Toxoplasma gondii</italic> tachyzoites to J774 murine macrophage cells</article-title><source>Infect. Immun.</source><year>1992</year><volume>60</volume><fpage>2337</fpage><lpage>2342</lpage><pub-id pub-id-type="doi">10.1128/iai.60.6.2337-2342.1992</pub-id><pub-id pub-id-type="pmid">1534073</pub-id>
</element-citation></ref><ref id="B64-toxins-17-00095"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kasper</surname><given-names>L.H.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Attachment and invasion of host cells by <italic toggle="yes">Toxoplasma gondii</italic></article-title><source>Parasitol. Today</source><year>1994</year><volume>10</volume><fpage>184</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/0169-4758(94)90026-4</pub-id><pub-id pub-id-type="pmid">15275469</pub-id>
</element-citation></ref><ref id="B65-toxins-17-00095"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonhomme</surname><given-names>A.</given-names></name>
<name><surname>Bouchot</surname><given-names>A.</given-names></name>
<name><surname>Pezzella</surname><given-names>N.</given-names></name>
<name><surname>Gomez</surname><given-names>J.</given-names></name>
<name><surname>Le Moal</surname><given-names>H.</given-names></name>
<name><surname>Pinon</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Signaling during the invasion of host cells by <italic toggle="yes">Toxoplasma gondii</italic></article-title><source>FEMS Microbiol. Rev.</source><year>1999</year><volume>23</volume><fpage>551</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.1999.tb00413.x</pub-id><pub-id pub-id-type="pmid">10525166</pub-id>
</element-citation></ref><ref id="B66-toxins-17-00095"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nikai</surname><given-names>T.</given-names></name>
<name><surname>Taniguchi</surname><given-names>K.</given-names></name>
<name><surname>Komori</surname><given-names>Y.</given-names></name>
<name><surname>Masuda</surname><given-names>K.</given-names></name>
<name><surname>Fox</surname><given-names>J.W.</given-names></name>
<name><surname>Sugihara</surname><given-names>H.</given-names></name>
</person-group><article-title>Primary structure and functional characterization of bilitoxin-1, a novel dimeric P-II snake venom metalloproteinase from <italic toggle="yes">Agkistrodon bilineatus</italic> venom</article-title><source>Arch. Biochem. Biophys.</source><year>2000</year><volume>378</volume><fpage>6</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1006/abbi.2000.1795</pub-id><pub-id pub-id-type="pmid">10871038</pub-id>
</element-citation></ref><ref id="B67-toxins-17-00095"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Geyer</surname><given-names>A.</given-names></name>
<name><surname>Fitzpatrick</surname><given-names>T.B.</given-names></name>
<name><surname>Pawelek</surname><given-names>P.D.</given-names></name>
<name><surname>Kitzing</surname><given-names>K.</given-names></name>
<name><surname>Vrielink</surname><given-names>A.</given-names></name>
<name><surname>Ghisla</surname><given-names>S.</given-names></name>
<name><surname>Macheroux</surname><given-names>P.</given-names></name>
</person-group><article-title>Structure and characterization of the glycan moiety of L-amino-acid oxidase from the Malayan pit viper <italic toggle="yes">Calloselasma rhodostoma</italic></article-title><source>Eur. J. Biochem.</source><year>2001</year><volume>268</volume><fpage>4044</fpage><lpage>4053</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.2001.02321.x</pub-id><pub-id pub-id-type="pmid">11453999</pub-id>
</element-citation></ref><ref id="B68-toxins-17-00095"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lochnit</surname><given-names>G.</given-names></name>
<name><surname>Geyer</surname><given-names>R.</given-names></name>
</person-group><article-title>Carbohydrate structure analysis of batroxobin, a thrombin-like serine protease from <italic toggle="yes">Bothrops moojeni</italic> venom</article-title><source>Eur. J. Biochem.</source><year>1995</year><volume>228</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20326.x</pub-id><pub-id pub-id-type="pmid">7737180</pub-id>
</element-citation></ref><ref id="B69-toxins-17-00095"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Osipov</surname><given-names>A.V.</given-names></name>
<name><surname>Astapova</surname><given-names>M.V.</given-names></name>
<name><surname>Tsetlin</surname><given-names>V.I.</given-names></name>
<name><surname>Utkin</surname><given-names>Y.N.</given-names></name>
</person-group><article-title>The first representative of glycosylated three-fingered toxins. Cytotoxin from the <italic toggle="yes">Naja kaouthia</italic> cobra venom</article-title><source>Eur. J. Biochem.</source><year>2004</year><volume>271</volume><fpage>2018</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.2004.04115.x</pub-id><pub-id pub-id-type="pmid">15128311</pub-id>
</element-citation></ref><ref id="B70-toxins-17-00095"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soares</surname><given-names>S.G.</given-names></name>
<name><surname>Oliveira</surname><given-names>L.L.</given-names></name>
</person-group><article-title>Venom-sweet-venom: <italic toggle="yes">N</italic>-linked glycosylation in snake venom toxins</article-title><source>Protein Pept. Lett.</source><year>2009</year><volume>16</volume><fpage>913</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.2174/092986609788923293</pub-id><pub-id pub-id-type="pmid">19689418</pub-id>
</element-citation></ref><ref id="B71-toxins-17-00095"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>F.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
<name><surname>Zhu</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Ji</surname><given-names>Y.</given-names></name>
<name><surname>Niu</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Teng</surname><given-names>M.</given-names></name>
</person-group><article-title>Crystal structure and activating effect on RyRs of AhV_TL-I, a glycosylated thrombin-like enzyme from <italic toggle="yes">Agkistrodon halys</italic> snake venom</article-title><source>Arch. Toxicol.</source><year>2013</year><volume>87</volume><fpage>535</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1007/s00204-012-0957-5</pub-id><pub-id pub-id-type="pmid">23052203</pub-id>
</element-citation></ref><ref id="B72-toxins-17-00095"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sartim</surname><given-names>M.A.</given-names></name>
<name><surname>Riul</surname><given-names>T.B.</given-names></name>
<name><surname>Del Cistia-Andrade</surname><given-names>C.</given-names></name>
<name><surname>Stowell</surname><given-names>S.R.</given-names></name>
<name><surname>Arthur</surname><given-names>C.M.</given-names></name>
<name><surname>Sorgi</surname><given-names>C.A.</given-names></name>
<name><surname>Faccioli</surname><given-names>L.H.</given-names></name>
<name><surname>Cummings</surname><given-names>R.D.</given-names></name>
<name><surname>Dias-Baruffi</surname><given-names>M.</given-names></name>
<name><surname>Sampaio</surname><given-names>S.V.</given-names></name>
</person-group><article-title>Galatrox is a C-type lectin in <italic toggle="yes">Bothrops atrox</italic> snake venom that selectively binds LacNAc-terminated glycans and can induce acute inflammation</article-title><source>Glycobiology</source><year>2014</year><volume>24</volume><fpage>1010</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwu061</pub-id><pub-id pub-id-type="pmid">24973254</pub-id>
</element-citation></ref><ref id="B73-toxins-17-00095"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y.M.</given-names></name>
<name><surname>Tsai</surname><given-names>I.H.</given-names></name>
<name><surname>Chen</surname><given-names>J.M.</given-names></name>
<name><surname>Cheng</surname><given-names>A.C.</given-names></name>
<name><surname>Khoo</surname><given-names>K.H.</given-names></name>
</person-group><article-title>Correlation between the glycan variations and defibrinogenating activities of acutobin and its recombinant glycoforms</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e100354</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100354</pub-id><pub-id pub-id-type="pmid">24945257</pub-id>
</element-citation></ref><ref id="B74-toxins-17-00095"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andrade-Silva</surname><given-names>D.</given-names></name>
<name><surname>Ashline</surname><given-names>D.</given-names></name>
<name><surname>Tran</surname><given-names>T.</given-names></name>
<name><surname>Lopes</surname><given-names>A.S.</given-names></name>
<name><surname>Travaglia Cardoso</surname><given-names>S.R.</given-names></name>
<name><surname>Reis</surname><given-names>M.D.S.</given-names></name>
<name><surname>Zelanis</surname><given-names>A.</given-names></name>
<name><surname>Serrano</surname><given-names>S.M.T.</given-names></name>
<name><surname>Reinhold</surname><given-names>V.</given-names></name>
</person-group><article-title>Structures of <italic toggle="yes">N</italic>-Glycans of <italic toggle="yes">Bothrops</italic> Venoms Revealed as Molecular Signatures that Contribute to Venom Phenotype in Viperid Snakes</article-title><source>Mol. Cell. Proteom.</source><year>2018</year><volume>17</volume><fpage>1261</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1074/mcp.RA118.000748</pub-id><pub-id pub-id-type="pmid">29716988</pub-id>
</element-citation></ref><ref id="B75-toxins-17-00095"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Br&#x000e1;s-Costa</surname><given-names>C.</given-names></name>
<name><surname>Alencar Chaves</surname><given-names>A.F.</given-names></name>
<name><surname>Trevisan-Silva</surname><given-names>D.</given-names></name>
<name><surname>Menezes</surname><given-names>M.C.</given-names></name>
<name><surname>Rocha</surname><given-names>M.M.T.</given-names></name>
<name><surname>Cajado-Carvalho</surname><given-names>D.</given-names></name>
<name><surname>Andrade-Silva</surname><given-names>D.</given-names></name>
<name><surname>Serrano</surname><given-names>S.M.T.</given-names></name>
</person-group><article-title>Sialic acid-containing glycans play a role in the activity of snake venom proteases</article-title><source>Biochimie</source><year>2023</year><volume>204</volume><fpage>140</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2022.09.011</pub-id><pub-id pub-id-type="pmid">36210615</pub-id>
</element-citation></ref><ref id="B76-toxins-17-00095"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Albulescu</surname><given-names>L.O.</given-names></name>
<name><surname>Hale</surname><given-names>M.S.</given-names></name>
<name><surname>Ainsworth</surname><given-names>S.</given-names></name>
<name><surname>Alsolaiss</surname><given-names>J.</given-names></name>
<name><surname>Crittenden</surname><given-names>E.</given-names></name>
<name><surname>Calvete</surname><given-names>J.J.</given-names></name>
<name><surname>Evans</surname><given-names>C.</given-names></name>
<name><surname>Wilkinson</surname><given-names>M.C.</given-names></name>
<name><surname>Harrison</surname><given-names>R.A.</given-names></name>
<name><surname>Kool</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite</article-title><source>Sci. Transl. Med.</source><year>2020</year><volume>12</volume><fpage>eaay8314</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aay8314</pub-id><pub-id pub-id-type="pmid">32376771</pub-id>
</element-citation></ref><ref id="B77-toxins-17-00095"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mandelbaum</surname><given-names>F.R.</given-names></name>
<name><surname>Reichel</surname><given-names>A.P.</given-names></name>
<name><surname>Assakura</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Isolation and characterization of a proteolytic enzyme from the venom of the snake <italic toggle="yes">Bothrops jararaca</italic> (Jararaca)</article-title><source>Toxicon</source><year>1982</year><volume>20</volume><fpage>955</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(82)90098-8</pub-id><pub-id pub-id-type="pmid">6819660</pub-id>
</element-citation></ref><ref id="B78-toxins-17-00095"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.J.</given-names></name>
<name><surname>Chen</surname><given-names>Z.X.</given-names></name>
<name><surname>He</surname><given-names>Y.Z.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
</person-group><article-title>Effect of calcium on proteolytic activity and conformation of hemorrhagic toxin I from five pace snake (<italic toggle="yes">Agkistrodon acutus</italic>) venom</article-title><source>Toxicon</source><year>1984</year><volume>22</volume><fpage>931</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(84)90184-3</pub-id><pub-id pub-id-type="pmid">6395446</pub-id>
</element-citation></ref><ref id="B79-toxins-17-00095"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pretzer</surname><given-names>D.</given-names></name>
<name><surname>Schulteis</surname><given-names>B.</given-names></name>
<name><surname>Vander Velde</surname><given-names>D.G.</given-names></name>
<name><surname>Smith</surname><given-names>C.D.</given-names></name>
<name><surname>Mitchell</surname><given-names>J.W.</given-names></name>
<name><surname>Manning</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Effect of zinc binding on the structure and stability of fibrolase, a fibrinolytic protein from snake venom</article-title><source>Pharm. Res.</source><year>1992</year><volume>9</volume><fpage>870</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1023/A:1015840613799</pub-id><pub-id pub-id-type="pmid">1437999</pub-id>
</element-citation></ref><ref id="B80-toxins-17-00095"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Howes</surname><given-names>J.M.</given-names></name>
<name><surname>Theakston</surname><given-names>R.D.</given-names></name>
<name><surname>Laing</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators</article-title><source>Toxicon</source><year>2007</year><volume>49</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2006.11.020</pub-id><pub-id pub-id-type="pmid">17196631</pub-id>
</element-citation></ref><ref id="B81-toxins-17-00095"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bradford</surname><given-names>M.M.</given-names></name>
</person-group><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source>Anal. Biochem.</source><year>1976</year><volume>72</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id><pub-id pub-id-type="pmid">942051</pub-id>
</element-citation></ref><ref id="B82-toxins-17-00095"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laemmli</surname><given-names>U.K.</given-names></name>
</person-group><article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title><source>Nature</source><year>1970</year><volume>227</volume><fpage>680</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1038/227680a0</pub-id><pub-id pub-id-type="pmid">5432063</pub-id>
</element-citation></ref><ref id="B83-toxins-17-00095"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mosmann</surname><given-names>T.</given-names></name>
</person-group><article-title>Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays</article-title><source>J. Immunol. Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id><pub-id pub-id-type="pmid">6606682</pub-id>
</element-citation></ref><ref id="B84-toxins-17-00095"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castro</surname><given-names>A.S.</given-names></name>
<name><surname>Alves</surname><given-names>C.M.</given-names></name>
<name><surname>Angeloni</surname><given-names>M.B.</given-names></name>
<name><surname>Gomes</surname><given-names>A.O.</given-names></name>
<name><surname>Barbosa</surname><given-names>B.F.</given-names></name>
<name><surname>Franco</surname><given-names>P.S.</given-names></name>
<name><surname>Silva</surname><given-names>D.A.</given-names></name>
<name><surname>Martins-Filho</surname><given-names>O.A.</given-names></name>
<name><surname>Mineo</surname><given-names>J.R.</given-names></name>
<name><surname>Mineo</surname><given-names>T.W.</given-names></name>
<etal/>
</person-group><article-title>Trophoblast cells are able to regulate monocyte activity to control <italic toggle="yes">Toxoplasma gondii</italic> infection</article-title><source>Placenta</source><year>2013</year><volume>34</volume><fpage>240</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2012.12.006</pub-id><pub-id pub-id-type="pmid">23294571</pub-id>
</element-citation></ref><ref id="B85-toxins-17-00095"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teixeira</surname><given-names>S.C.</given-names></name>
<name><surname>de Souza</surname><given-names>G.</given-names></name>
<name><surname>Borges</surname><given-names>B.C.</given-names></name>
<name><surname>de Ara&#x000fa;jo</surname><given-names>T.E.</given-names></name>
<name><surname>Rosini</surname><given-names>A.M.</given-names></name>
<name><surname>Aguila</surname><given-names>F.A.</given-names></name>
<name><surname>Ambr&#x000f3;sio</surname><given-names>S.R.</given-names></name>
<name><surname>Veneziani</surname><given-names>R.C.S.</given-names></name>
<name><surname>Bastos</surname><given-names>J.K.</given-names></name>
<name><surname>Silva</surname><given-names>M.J.B.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Copaifera</italic> spp. oleoresins impair <italic toggle="yes">Toxoplasma gondii</italic> infection in both human trophoblastic cells and human placental explants</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>15158</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-72230-0</pub-id><pub-id pub-id-type="pmid">32938966</pub-id>
</element-citation></ref><ref id="B86-toxins-17-00095"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gomes</surname><given-names>M.S.</given-names></name>
<name><surname>de Queiroz</surname><given-names>M.R.</given-names></name>
<name><surname>Mamede</surname><given-names>C.C.</given-names></name>
<name><surname>Mendes</surname><given-names>M.M.</given-names></name>
<name><surname>Hamaguchi</surname><given-names>A.</given-names></name>
<name><surname>Homsi-Brandeburgo</surname><given-names>M.I.</given-names></name>
<name><surname>Sousa</surname><given-names>M.V.</given-names></name>
<name><surname>Aquino</surname><given-names>E.N.</given-names></name>
<name><surname>Castro</surname><given-names>M.S.</given-names></name>
<name><surname>de Oliveira</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Purification and functional characterization of a new metalloproteinase (BleucMP) from <italic toggle="yes">Bothrops leucurus</italic> snake venom</article-title><source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source><year>2011</year><volume>153</volume><fpage>290</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.cbpc.2010.11.008</pub-id><pub-id pub-id-type="pmid">21130897</pub-id>
</element-citation></ref><ref id="B87-toxins-17-00095"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Waterhouse</surname><given-names>A.</given-names></name>
<name><surname>Bertoni</surname><given-names>M.</given-names></name>
<name><surname>Bienert</surname><given-names>S.</given-names></name>
<name><surname>Studer</surname><given-names>G.</given-names></name>
<name><surname>Tauriello</surname><given-names>G.</given-names></name>
<name><surname>Gumienny</surname><given-names>R.</given-names></name>
<name><surname>Heer</surname><given-names>F.T.</given-names></name>
<name><surname>de Beer</surname><given-names>T.A.P.</given-names></name>
<name><surname>Rempfer</surname><given-names>C.</given-names></name>
<name><surname>Bordoli</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>SWISS-MODEL: Homology modelling of protein structures and complexes</article-title><source>Nucleic Acids Res.</source><year>2018</year><volume>46</volume><fpage>W296</fpage><lpage>W303</lpage><pub-id pub-id-type="doi">10.1093/nar/gky427</pub-id><pub-id pub-id-type="pmid">29788355</pub-id>
</element-citation></ref><ref id="B88-toxins-17-00095"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>UniProt Consortium</collab>
</person-group><article-title>UniProt: The Universal Protein Knowledgebase in 2023</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><fpage>D523</fpage><lpage>D531</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac1052</pub-id><pub-id pub-id-type="pmid">36408920</pub-id>
</element-citation></ref><ref id="B89-toxins-17-00095"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muniz</surname><given-names>J.R.</given-names></name>
<name><surname>Ambrosio</surname><given-names>A.L.</given-names></name>
<name><surname>Selistre-de-Araujo</surname><given-names>H.S.</given-names></name>
<name><surname>Cominetti</surname><given-names>M.R.</given-names></name>
<name><surname>Moura-da-Silva</surname><given-names>A.M.</given-names></name>
<name><surname>Oliva</surname><given-names>G.</given-names></name>
<name><surname>Garratt</surname><given-names>R.C.</given-names></name>
<name><surname>Souza</surname><given-names>D.H.</given-names></name>
</person-group><article-title>The three-dimensional structure of bothropasin, the main hemorrhagic factor from <italic toggle="yes">Bothrops jararaca</italic> venom: Insights for a new classification of snake venom metalloprotease subgroups</article-title><source>Toxicon</source><year>2008</year><volume>52</volume><fpage>807</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2008.08.021</pub-id><pub-id pub-id-type="pmid">18831982</pub-id>
</element-citation></ref><ref id="B90-toxins-17-00095"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berman</surname><given-names>H.M.</given-names></name>
<name><surname>Westbrook</surname><given-names>J.</given-names></name>
<name><surname>Feng</surname><given-names>Z.</given-names></name>
<name><surname>Gilliland</surname><given-names>G.</given-names></name>
<name><surname>Bhat</surname><given-names>T.N.</given-names></name>
<name><surname>Weissig</surname><given-names>H.</given-names></name>
<name><surname>Shindyalov</surname><given-names>I.N.</given-names></name>
<name><surname>Bourne</surname><given-names>P.E.</given-names></name>
</person-group><article-title>The Protein Data Bank</article-title><source>Nucleic Acids Res.</source><year>2000</year><volume>28</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id><pub-id pub-id-type="pmid">10592235</pub-id>
</element-citation></ref><ref id="B91-toxins-17-00095"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>C.J.</given-names></name>
<name><surname>Headd</surname><given-names>J.J.</given-names></name>
<name><surname>Moriarty</surname><given-names>N.W.</given-names></name>
<name><surname>Prisant</surname><given-names>M.G.</given-names></name>
<name><surname>Videau</surname><given-names>L.L.</given-names></name>
<name><surname>Deis</surname><given-names>L.N.</given-names></name>
<name><surname>Verma</surname><given-names>V.</given-names></name>
<name><surname>Keedy</surname><given-names>D.A.</given-names></name>
<name><surname>Hintze</surname><given-names>B.J.</given-names></name>
<name><surname>Chen</surname><given-names>V.B.</given-names></name>
<etal/>
</person-group><article-title>MolProbity: More and better reference data for improved all-atom structure validation</article-title><source>Protein Sci.</source><year>2018</year><volume>27</volume><fpage>293</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1002/pro.3330</pub-id><pub-id pub-id-type="pmid">29067766</pub-id>
</element-citation></ref><ref id="B92-toxins-17-00095"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Studer</surname><given-names>G.</given-names></name>
<name><surname>Rempfer</surname><given-names>C.</given-names></name>
<name><surname>Waterhouse</surname><given-names>A.M.</given-names></name>
<name><surname>Gumienny</surname><given-names>R.</given-names></name>
<name><surname>Haas</surname><given-names>J.</given-names></name>
<name><surname>Schwede</surname><given-names>T.</given-names></name>
</person-group><article-title>QMEANDisCo-distance constraints applied on model quality estimation</article-title><source>Bioinformatics</source><year>2020</year><volume>36</volume><fpage>1765</fpage><lpage>1771</lpage><comment>Erratum in <italic toggle="yes">Bioinformatics</italic>
<bold>2020</bold>, <italic toggle="yes">36</italic>, 2647</comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btz828</pub-id><pub-id pub-id-type="pmid">31697312</pub-id>
</element-citation></ref><ref id="B93-toxins-17-00095"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Colovos</surname><given-names>C.</given-names></name>
<name><surname>Yeates</surname><given-names>T.O.</given-names></name>
</person-group><article-title>Verification of protein structures: Patterns of nonbonded atomic interactions</article-title><source>Protein Sci.</source><year>1993</year><volume>2</volume><fpage>1511</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1002/pro.5560020916</pub-id><pub-id pub-id-type="pmid">8401235</pub-id>
</element-citation></ref><ref id="B94-toxins-17-00095"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dolinsky</surname><given-names>T.J.</given-names></name>
<name><surname>Nielsen</surname><given-names>J.E.</given-names></name>
<name><surname>McCammon</surname><given-names>J.A.</given-names></name>
<name><surname>Baker</surname><given-names>N.A.</given-names></name>
</person-group><article-title>PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</article-title><source>Nucleic Acids Res.</source><year>2004</year><volume>32</volume><fpage>W665</fpage><lpage>W667</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh381</pub-id><pub-id pub-id-type="pmid">15215472</pub-id>
</element-citation></ref><ref id="B95-toxins-17-00095"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madeira</surname><given-names>F.</given-names></name>
<name><surname>Pearce</surname><given-names>M.</given-names></name>
<name><surname>Tivey</surname><given-names>A.R.N.</given-names></name>
<name><surname>Basutkar</surname><given-names>P.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Edbali</surname><given-names>O.</given-names></name>
<name><surname>Madhusoodanan</surname><given-names>N.</given-names></name>
<name><surname>Kolesnikov</surname><given-names>A.</given-names></name>
<name><surname>Lopez</surname><given-names>R.</given-names></name>
</person-group><article-title>Search and sequence analysis tools services from EMBL-EBI in 2022</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>W276</fpage><lpage>W279</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac240</pub-id><pub-id pub-id-type="pmid">35412617</pub-id>
</element-citation></ref><ref id="B96-toxins-17-00095"><label>96.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Shimoyama</surname><given-names>Y.</given-names></name>
</person-group><article-title>pyMSAviz: MSA Visualization Python Package for Sequence Analysis</article-title><year>2022</year><comment>Available online: <ext-link xlink:href="https://github.com/moshi4/pyMSAviz" ext-link-type="uri">https://github.com/moshi4/pyMSAviz</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-04">(accessed on 4 July 2023)</date-in-citation></element-citation></ref><ref id="B97-toxins-17-00095"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Cheng</surname><given-names>T.</given-names></name>
<name><surname>Gindulyte</surname><given-names>A.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
<name><surname>He</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Shoemaker</surname><given-names>B.A.</given-names></name>
<name><surname>Thiessen</surname><given-names>P.A.</given-names></name>
<name><surname>Yu</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>PubChem 2023 update</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><fpage>D1373</fpage><lpage>D1380</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac956</pub-id><pub-id pub-id-type="pmid">36305812</pub-id>
</element-citation></ref><ref id="B98-toxins-17-00095"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hanwell</surname><given-names>M.D.</given-names></name>
<name><surname>Curtis</surname><given-names>D.E.</given-names></name>
<name><surname>Lonie</surname><given-names>D.C.</given-names></name>
<name><surname>Vandermeersch</surname><given-names>T.</given-names></name>
<name><surname>Zurek</surname><given-names>E.</given-names></name>
<name><surname>Hutchison</surname><given-names>G.R.</given-names></name>
</person-group><article-title>Avogadro: An advanced semantic chemical editor, visualization, and analysis platform</article-title><source>J. Cheminform.</source><year>2012</year><volume>4</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-4-17</pub-id><pub-id pub-id-type="pmid">22889332</pub-id>
</element-citation></ref><ref id="B99-toxins-17-00095"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jurrus</surname><given-names>E.</given-names></name>
<name><surname>Engel</surname><given-names>D.</given-names></name>
<name><surname>Star</surname><given-names>K.</given-names></name>
<name><surname>Monson</surname><given-names>K.</given-names></name>
<name><surname>Brandi</surname><given-names>J.</given-names></name>
<name><surname>Felberg</surname><given-names>L.E.</given-names></name>
<name><surname>Brookes</surname><given-names>D.H.</given-names></name>
<name><surname>Wilson</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Liles</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Improvements to the APBS biomolecular solvation software suite</article-title><source>Protein Sci.</source><year>2018</year><volume>27</volume><fpage>112</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1002/pro.3280</pub-id><pub-id pub-id-type="pmid">28836357</pub-id>
</element-citation></ref><ref id="B100-toxins-17-00095"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abraham</surname><given-names>M.K.</given-names></name>
<name><surname>Murtola</surname><given-names>T.</given-names></name>
<name><surname>Schulz</surname><given-names>R.</given-names></name>
<name><surname>P&#x000e1;ll</surname><given-names>S.</given-names></name>
<name><surname>Smith</surname><given-names>J.C.</given-names></name>
<name><surname>Hess</surname><given-names>B.</given-names></name>
<name><surname>Lindahl</surname><given-names>E.</given-names></name>
</person-group><article-title>GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><year>2015</year><volume>1&#x02013;2</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id></element-citation></ref><ref id="B101-toxins-17-00095"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sousa da Silva</surname><given-names>A.W.</given-names></name>
<name><surname>Vranken</surname><given-names>W.F.</given-names></name>
</person-group><article-title>ACPYPE&#x02014;AnteChamber PYthon Parser interfacE</article-title><source>BMC Res. Notes</source><year>2012</year><volume>5</volume><elocation-id>367</elocation-id><pub-id pub-id-type="doi">10.1186/1756-0500-5-367</pub-id><pub-id pub-id-type="pmid">22824207</pub-id>
</element-citation></ref><ref id="B102-toxins-17-00095"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hornak</surname><given-names>V.</given-names></name>
<name><surname>Abel</surname><given-names>R.</given-names></name>
<name><surname>Okur</surname><given-names>A.</given-names></name>
<name><surname>Strockbine</surname><given-names>B.</given-names></name>
<name><surname>Roitberg</surname><given-names>A.</given-names></name>
<name><surname>Simmerling</surname><given-names>C.</given-names></name>
</person-group><article-title>Comparison of multiple Amber force fields and development of improved protein backbone parameters</article-title><source>Proteins</source><year>2006</year><volume>65</volume><fpage>712</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1002/prot.21123</pub-id><pub-id pub-id-type="pmid">16981200</pub-id>
</element-citation></ref><ref id="B103-toxins-17-00095"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>William</surname><given-names>L.J.</given-names></name>
<name><surname>Jayaraman</surname><given-names>C.</given-names></name>
<name><surname>Jeffry</surname><given-names>D.M.</given-names></name>
<name><surname>Roger</surname><given-names>W.I.</given-names></name>
<name><surname>Michal</surname><given-names>L.K.</given-names></name>
</person-group><article-title>Comparison of simple potential functions for simulating liquid water</article-title><source>J. Chem. Phys.</source><year>1983</year><volume>79</volume><fpage>926</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1063/1.445869</pub-id></element-citation></ref><ref id="B104-toxins-17-00095"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Humphrey</surname><given-names>W.</given-names></name>
<name><surname>Dalke</surname><given-names>A.</given-names></name>
<name><surname>Schulten</surname><given-names>K.</given-names></name>
</person-group><article-title>VMD: Visual molecular dynamics</article-title><source>J. Mol. Graph.</source><year>1996</year><volume>14</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id><pub-id pub-id-type="pmid">8744570</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxins-17-00095-f001"><label>Figure 1</label><caption><p>Cell viability and <italic toggle="yes">T. gondii</italic> proliferation assays treated with snake venom metalloproteinases. Cell viability (MTT) (<bold>A</bold>&#x02013;<bold>C</bold>) and <italic toggle="yes">T. gondii</italic> proliferation (<bold>D</bold>&#x02013;<bold>F</bold>) with different concentrations of the metalloproteinases: BpMP-I (<bold>A</bold>,<bold>D</bold>), Jar (<bold>B</bold>,<bold>E</bold>), and Jar-C (<bold>C</bold>,<bold>F</bold>) (ranging from 40 to 2.5 &#x000b5;g/mL for the viability assay; or from 40 to 10 &#x000b5;g/mL for the parasite proliferation assay). For both experiments, RPMI 1640 medium served as the negative control (Ctrl). Data were obtained from three independent experiments, each consisting of 8 replicates. The results are expressed as the mean percentage (%) of cell viability for the MTT assay &#x000b1; standard error of the mean (SEM); and the mean percentage (%) of proliferation &#x000b1; standard error of the mean (SEM) of <italic toggle="yes">T. gondii</italic> for the proliferation assay. Statistical analyses were performed using one-way ANOVA and Dunn&#x02019;s multiple comparison test to identify significant differences between groups (<italic toggle="yes">p</italic> &#x0003c; 0.05). The negative control of both assays was considered 100% cell viability or 100% <italic toggle="yes">T. gondii</italic> proliferation. The significance levels are denoted as **** for <italic toggle="yes">p</italic> &#x0003c; 0.0001, *** for <italic toggle="yes">p</italic> &#x0003c; 0.001, and ** for <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="toxins-17-00095-g001" position="float"/></fig><fig position="float" id="toxins-17-00095-f002"><label>Figure 2</label><caption><p>Evaluation of cytokines in HeLa cells infected with <italic toggle="yes">T. gondii</italic> after a 24 h treatment with SVMPs. HeLa cells were infected or not with <italic toggle="yes">T. gondii</italic> tachyzoites and subsequently treated with the metalloproteinases (40 &#x000b5;g/mL): BpMP-I (<bold>A</bold>&#x02013;<bold>C</bold>), Jar (<bold>D</bold>&#x02013;<bold>F</bold>), and Jar-C (<bold>G</bold>&#x02013;<bold>I</bold>). After that, the levels of the cytokines IL-6 (<bold>A</bold>,<bold>D</bold>,<bold>G</bold>), IL-8 (<bold>B</bold>,<bold>E</bold>,<bold>H</bold>), and MIF (<bold>C</bold>,<bold>F</bold>,<bold>I</bold>) were quantified by the ELISA method. As the negative control (Ctrl), RPMI 1640 medium was used. Data were obtained from three independent experiments, each one comprising 8 replicates, and the results are expressed as mean &#x000b1; standard error of the mean (SEM). Statistical analyses were performed using one-way ANOVA and &#x00160;&#x000ed;d&#x000e1;k&#x02019;s multiple comparison test to identify significant differences between groups (<italic toggle="yes">p</italic> &#x0003c; 0.05). The significance levels are denoted as **** for <italic toggle="yes">p</italic> &#x0003c; 0.0001, ** for <italic toggle="yes">p</italic> &#x0003c; 0.01, and * for <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="toxins-17-00095-g002" position="float"/></fig><fig position="float" id="toxins-17-00095-f003"><label>Figure 3</label><caption><p>Assessment of snake venom metalloproteinase activity on <italic toggle="yes">T. gondii</italic> adhesion and invasion in HeLa cells. HeLa cells were subjected to pretreatment with Jar-C or Jar (40 &#x003bc;g/mL) for 30 min (<bold>A</bold>) or 24 h (<bold>B</bold>) and then infected with <italic toggle="yes">T. gondii</italic> tachyzoites for 3 h. Alternatively, <italic toggle="yes">T. gondii</italic> tachyzoites were previously treated for 30 min with Jar-C or Jar (40 &#x003bc;g/mL) before being allowed to infect HeLa cells for 3 h (<bold>C</bold>). The images (<bold>D</bold>&#x02013;<bold>F</bold>) were captured using a confocal microscope and display the adhered parasites stained with Alexa Fluor 488 conjugated anti-mouse IgG (green). HeLa cells nuclei were counterstained using DAPI (blue). Intracellular and adhered parasites are shown in green and red/yellow, respectively. As the negative control (Ctrl), RPMI 1640 medium supplemented with 5% FBS was employed. The dataset was derived from three independent experiments, each comprising 8 replicates, and the results are expressed as mean &#x000b1; standard error of the mean (SEM). Statistical analyses were performed using one-way ANOVA and &#x00160;&#x000ed;d&#x000e1;k&#x02019;s multiple comparison test to identify significant differences between groups (<italic toggle="yes">p</italic> &#x0003c; 0.05). The significance levels are indicated as **** for <italic toggle="yes">p</italic> &#x0003c; 0.0001, *** for <italic toggle="yes">p</italic> &#x0003c; 0.001, ** for <italic toggle="yes">p</italic> &#x0003c; 0.01, and * for <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="toxins-17-00095-g003" position="float"/></fig><fig position="float" id="toxins-17-00095-f004"><label>Figure 4</label><caption><p>Evaluation of azocaseinolytic activity and analysis of enzymatic domain dependence in controlling <italic toggle="yes">T. gondii</italic> infection. HeLa cell viability following a 24 h treatment with 1 mM of EDTA (<bold>A</bold>). Azocaseinolytic activity of BpMP-I (<bold>B</bold>) and Jar (<bold>C</bold>) was evaluated in the presence or absence of EDTA. For this assay, BpMP-I and jararhagin metalloproteinases were incubated with azocasein, both with and without EDTA. Results are presented as a unit (U) of azocaseinolytic activity, defined as an increase of 0.01 absorbance units per minute. The proliferation of <italic toggle="yes">T. gondii</italic> in HeLa cells treated with BpMP-I (<bold>D</bold>), Jar (<bold>E</bold>), and Jar-C (<bold>F</bold>) in conjunction with EDTA was also examined. In this assay, HeLa cells were initially infected with <italic toggle="yes">T. gondii</italic> tachyzoites for 3 h and then treated for 24 h with the respective metalloproteinases + EDTA. RPMI 1640 medium supplemented with 5% FBS and EDTA alone were employed as controls. Data were obtained from three independent experiments, each comprising 8 replicates, and the results are expressed as mean &#x000b1; standard error of the mean (SEM). Statistical analyses were performed using the unpaired <italic toggle="yes">t</italic>-test (<bold>A</bold>), one-way ANOVA, and Dunn&#x02019;s (<bold>B</bold>,<bold>C</bold>) or &#x00160;&#x000ed;d&#x000e1;k&#x02019;s (<bold>D</bold>&#x02013;<bold>F</bold>) multiple comparison tests to identify significant differences between groups (<italic toggle="yes">p</italic> &#x0003c; 0.05). The significance levels are presented as *** for <italic toggle="yes">p</italic> &#x0003c; 0.001, ** for <italic toggle="yes">p</italic> &#x0003c; 0.01, and * for <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="toxins-17-00095-g004" position="float"/></fig><fig position="float" id="toxins-17-00095-f005"><label>Figure 5</label><caption><p>Molecular modeling of Jar and Jar-C. (<bold>A</bold>) Jar and Jar-C domains. The metalloproteinase (M), disintegrin-like (D) and cysteine-rich (C) domains are represented in the image. The M domain is colored in pink, the D domain in light blue and the C domain in orange. Jar is formed by the M, D and C domains, while Jar-C is formed by the identical D and C domains. Disulfide bonds are shown as yellow sticks. The Zn<sup>2+</sup> and Ca<sup>2+</sup> binding sites are evidenced by gray boxes. The Zn<sup>2+</sup> and Ca<sup>2+</sup> are represented as spheres and the residues in the binding site as sticks, with the carbon, hydrogen, nitrogen, and oxygen atoms in gray, white, blue, and red, respectively. Electrostatic surface of Jar (<bold>B</bold>) and Jar-C (<bold>C</bold>). The blue, white, and red colors indicate positive, neutral, and negative charges, respectively.</p></caption><graphic xlink:href="toxins-17-00095-g005" position="float"/></fig><fig position="float" id="toxins-17-00095-f006"><label>Figure 6</label><caption><p>Molecular dynamics of Jar. Structures of Jar in the absence (<bold>A</bold>) and presence (<bold>B</bold>) of EDTA. The proteins and EDTA are represented in the image and sticks, respectively. For clarity, the water molecules and Na<sup>+</sup> and Cl<sup>&#x02212;</sup> ions were hidden. RMSD (nm) of Jar in the absence (<bold>C</bold>) and presence (<bold>D</bold>) of EDTA. RMSF (nm) of Jar without (<bold>E</bold>) and with (<bold>F</bold>) EDTA. Radius of gyration (nm) of Jar in the absence (<bold>G</bold>) and presence (<bold>H</bold>) of EDTA. The central lines indicate the average values among the simulations contoured by the maximum and minimum values.</p></caption><graphic xlink:href="toxins-17-00095-g006" position="float"/></fig><fig position="float" id="toxins-17-00095-f007"><label>Figure 7</label><caption><p>Molecular dynamics of Jar-C. Structures of Jar-C in the absence (<bold>A</bold>) and presence (<bold>B</bold>) of EDTA. The proteins and EDTA are represented in the image and sticks, respectively. For clarity, the water molecules and Na<sup>+</sup> and Cl<sup>&#x02212;</sup> ions were hidden. RMSD (nm) of Jar-C in the presence (<bold>C</bold>) and absence (<bold>D</bold>) of EDTA. RMSF (nm) of Jar-C without (<bold>E</bold>) and with (<bold>F</bold>) EDTA. Radius of gyration (nm) of Jar-C in the presence (<bold>G</bold>) and absence (<bold>H</bold>) of EDTA. The central lines indicate the average values among the simulations contoured by the maximum and minimum values.</p></caption><graphic xlink:href="toxins-17-00095-g007" position="float"/></fig></floats-group></article>